BOK Financial NASDAQ: BOKF reported higher second-quarter 2026 earnings and record loan production, while executives said credit quality remained strong and raised the company’s full-year loan growth outlook.
The Tulsa-based financial services company earned $176.5 million, or $2.92 per diluted share, in the quarter, Chief Executive Officer Stacy Kymes said on the company’s earnings call. Adjusted for a net gain tied to the exchange of Visa Class B shares and a small securities portfolio repositioning, earnings were $156.5 million, or $2.59 per share.
Kymes described the quarter as “excellent” and said it reflected the company’s positioning for continued growth. He cited record quarterly loan growth, record fiduciary and asset management revenue, expense discipline and “outstanding” credit performance.
Get BOK Financial alerts:
Loan Growth Hits Company Record Total loans increased 3.4% sequentially, or 13.7% annualized, rising $896 million during the quarter. Kymes said that represented record new loan production for a single quarter in the company’s history. Year over year, loans were up 11.5%.
The growth was broad-based across business lines and geographies, according to Kymes. Nearly 70% of the year-over-year growth came from the company’s commercial and industrial portfolio.
Core C&I loans, which include the combined services and general business portfolios, rose 3.9% from the prior quarter and 11.1% from a year earlier. Kymes said the growth reflected a long-term strategy of investing in talent and deepening client relationships.
“As we’ve often said, growth follows relationships,” Kymes said.
Healthcare loans increased 3.2%, reflecting what management had previously described as strong activity and pipeline levels entering the quarter. Energy loans grew 1.6%. Commercial real estate loans were up marginally from the prior quarter and 6.6% year over year.
Mortgage finance also contributed to loan growth. Outstanding balances were $452 million at quarter-end, up $224 million, with active warehouse facilities totaling $870 million in commitments. Kymes said the business recorded its first month above breakeven during the quarter, less than a year after funding its first loan.
During the Q&A portion of the call, Kymes said the company expects mortgage finance to remain a tailwind in the second half of the year, while noting some seasonality in the business.
Credit Metrics Remain Strong BOK Financial reported nonperforming assets not guaranteed by the U.S. government of $55 million, up $2.8 million from the prior quarter. Nonperforming assets as a percentage of period-end loans and repossessed assets remained consistent with the prior quarter at 20 basis points.
Committed criticized assets decreased during the quarter and remained low relative to historical standards, Kymes said. Net charge-offs were $500,000 in the quarter and averaged three basis points over the last 12 months.
Kymes said the company saw no charge-off patterns or concentrations raising concerns about particular business lines or geographies. He also said BOK Financial continued to have no exposure to private credit facilities.
No provision for credit losses was required for the quarter, consistent with the prior quarter. Management said improvement in economic forecast assumptions was offset by loan growth. The combined allowance for credit losses was $323 million, or 1.19% of outstanding loans.
In response to an analyst question, Kymes said the company’s credit metrics were better than at CECL day one, and that, based on current credit conditions, the allowance ratio “could continue to fall.”
Fee Businesses Show Mixed Results Scott Grauer, Executive Vice President of Wealth Management, said fee income remained a solid contributor to revenue, though total fee income declined $7.8 million sequentially to $202 million.
Total trading revenue, including trading-related net interest income, decreased $9.7 million to $25 million. Grauer said results in the fixed-income business were affected by lower customer activity as longer-term rates increased from March through May. He said activity improved in June as market conditions stabilized.
“Overall, our activity levels were consistent with broader industry trends, which also saw a decline in MBS trading volumes during the quarter,” Grauer said.
Mortgage banking revenue declined $2 million from the prior quarter, which Grauer attributed to elevated long-term rates. Syndication revenue increased $3 million sequentially, supported by strong activity and customer demand, producing a record second quarter for that business.
Fiduciary and asset management revenue set a quarterly record, rising $4.5 million from the prior quarter. Grauer said the increase reflected higher trust fees and seasonal tax preparation fees. In the Q&A, he said seasonal tax preparation accounted for roughly one-third of the quarter-over-quarter increase.
Assets under management and administration increased $5.7 billion during the quarter to $129.3 billion, driven by higher market valuations and customer expansion. Compared with the same period last year, AUMA rose $11.4 billion, or nearly 10%.
Net Interest Income Rises; Expenses Controlled Chief Financial Officer Martin Grunst said net interest income increased $9.3 million, while the reported net interest margin expanded by 1 basis point. Excluding trading, core net interest income rose $6.5 million and core margin declined 2 basis points.
Grunst said core margin and net interest income benefited from loan and deposit growth and fixed-rate asset repricing. Those positives were offset by a 3-basis-point negative impact related to cash margin posted on behalf of energy derivative customers as oil prices moved higher. He said the impact was temporary and that the majority of the margin had already been returned as energy prices declined.
The company recognized a $30.9 million pre-tax gain from the exchange of Visa Class B shares. Grunst said BOK Financial used part of the gain to reposition a small portion of its securities portfolio, realizing $4.6 million of pre-tax losses. He said the move would improve yields on $268 million of reinvested securities.
Total expenses increased $7.5 million, driven by an $8.9 million rise in deferred compensation expense that was offset by gains recorded in other gains and losses. Excluding deferred compensation, total expenses declined $1.4 million. Personnel expense fell $6 million, while non-personnel expense rose $4.6 million, largely due to higher business promotion costs.
Management Raises Loan Growth Outlook BOK Financial raised its full-year 2026 loan growth guidance and now expects loans to grow more than 10%. Grunst said the first-half loan growth was strong and well-diversified.
The company maintained its total revenue guidance of mid-single-digit growth, but now expects to be in the upper portion of that range. Grunst said net interest income is expected to be in the upper half of the company’s $1.42 billion to $1.45 billion range, while fee income is expected to be in the lower half of the $820 million to $845 million range. In the Q&A, management clarified that the Visa gain is included in total revenue guidance but not in fee and commission guidance.
Expense growth is still expected to be in the low single digits, likely toward the lower end of that range. The company expects its full-year efficiency ratio to be approximately 62%, or near 63% excluding the Visa gain.
Management also said provision expense is expected to be below $20 million for full-year 2026.
Kymes said market disruption has created hiring opportunities for the company. BOK Financial added more than 25 teammates during the quarter, including more than 20 in Texas, along with additions in Colorado and Arizona. He said most of the hires were revenue producers and that the quarter’s loan growth was independent of those additions, given the longer sales cycle in C&I lending.
“We are entering the second half of the year from a position of strength, with strong business momentum and a solid foundation for continued growth,” Kymes said in closing remarks.
About BOK Financial (NASDAQ:BOKF)BOK Financial Corporation NASDAQ: BOKF, headquartered in Tulsa, Oklahoma, is a diversified financial services holding company serving businesses, professionals and individuals across the central and western United States. Through its banking subsidiary, BOK Financial offers a full suite of commercial banking, treasury and payment management services, as well as consumer deposit and lending solutions. The company's offerings also encompass wealth management, trust and asset management, investment banking, and insurance products designed to meet the needs of both retail and institutional clients.
The roots of BOK Financial date back to the founding of the Bank of Oklahoma in 1910.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in BOK Financial Right Now?Before you consider BOK Financial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BOK Financial wasn't on the list.
While BOK Financial currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Key Takeaways CNA is expected to benefit from strong retention, renewal pricing and new business across key segments. CNA's investment portfolio and conservative capital structure support earnings and financial flexibility. CNA continues to reward shareholders through dividend growth backed by strong capital & underwriting results. CNA Financial Corporation (CNA - Free Report) hit a 52-week high of $52.99 on July 20. Shares closed at $52.91 after gaining 18.6% in the past year, outperforming the industry and the sector.
With a capitalization of $14.31 billion, the average number of shares traded in the last three months was 0.5 million.
Image Source: Zacks Investment Research
CNA Trading Above 50-Day and 200-Day Moving AveragesShares of CNA Financial are trading above the 50-day and 200-day simple moving averages (SMA) of $46.01 and $46.60, respectively, indicating solid upward momentum. SMA is a widely used technical analysis tool to predict future price trends by analyzing historical price data.
Image Source: Zacks Investment Research
CNA Shares Are AffordableCNA Financial shares are trading at a discount compared to the Zacks Property and Casualty Insurance industry. Its forward price-to-book value of 1.32X is lower than the industry average of 1.45X, the Finance sector’s 4.45X and the Zacks S&P 500 Composite’s 8.03X. The insurer has a Value Score of A.
Shares of RenaissanceRe Holdings Ltd. (RNR - Free Report) , NMI Holdings Inc. (NMIH - Free Report) and First American Financial Corporation (FAF - Free Report) are also trading at a discount to the industry average.
Image Source: Zacks Investment Research
CNA’s Encouraging Growth ProjectionThe Zacks Consensus Estimate for CNA Financial’s 2026 revenues is pegged at $13.80 billion, implying a year-over-year improvement of 2.2%. The consensus estimate for 2027 earnings and revenues indicates an increase of 16.9% and 3.8%, respectively, from the corresponding 2026 estimates.
CNA’s Favorable Return on CapitalCNA Financial’s trailing 12-month ROE of 11.5% is better than the industry average of 7.4%.
Factors Favoring CNACNA Financial’s premiums should continue to grow on solid retention, favorable renewal premium change and new business growth across Specialty, Commercial and International segments.
An improving rate environment is favorable for an insurer. Amid the lower rate environment, the company’s fixed-income investment strategy with the highest allocations to diversified investment grade corporates, as well as highly rated municipal securities, should support investment results.
CNA Financial has a solid balance sheet with capital remaining above the target levels required for all ratings. CNA Financial continues to maintain a conservative capital structure. It maintains liquidity in the form of cash and short-term investments, which helps to sustain business variability.
Strong financial position enables CNA Financial to engage in shareholder-friendly moves like dividend hikes. The insurer’s dividend history is impressive, as it witnessed a 10-year CAGR (2015-2025) of 6.3%. The current dividend yield of 3.6% is better than the industry average of 0.2%. On the back of disciplined execution, denoted by strong underwriting results and confidence in future earnings performance, the insurer has been hiking dividends, apart from paying special dividends over the past couple of years. Thus, the company remains committed to returning more value to shareholders.
End NotesSolid retention, favorable renewal premium change and new business growth across its segments will continue to induce growth for CNA Financial. As part of wealth distribution to shareholders, CNA also has an impressive dividend history, reflecting capital strength, that is expected to be attractive to generate long-term value for shareholders.
Favorable growth estimates, higher return on capital and attractive valuation also add to the upside. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Investors looking for stocks in the Chemical - Diversified sector might want to consider either Avient (AVNT - Free Report) or Air Liquide (AIQUY - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.
Avient has a Zacks Rank of #2 (Buy), while Air Liquide has a Zacks Rank of #4 (Sell) right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that AVNT has an improving earnings outlook. But this is only part of the picture for value investors.
Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.
The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.
AVNT currently has a forward P/E ratio of 11.73, while AIQUY has a forward P/E of 28.24. We also note that AVNT has a PEG ratio of 1.13. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. AIQUY currently has a PEG ratio of 2.78.
Another notable valuation metric for AVNT is its P/B ratio of 1.37. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, AIQUY has a P/B of 4.22.
These are just a few of the metrics contributing to AVNT's Value grade of A and AIQUY's Value grade of F.
AVNT stands above AIQUY thanks to its solid earnings outlook, and based on these valuation figures, we also feel that AVNT is the superior value option right now.
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.
Based in Avon Lake, Avient (AVNT - Free Report) is in the Basic Materials sector, and so far this year, shares have seen a price change of 15.59%. Currently paying a dividend of $0.28 per share, the company has a dividend yield of 3.05%. In comparison, the Chemical - Diversified industry's yield is 1.66%, while the S&P 500's yield is 1.35%.
Looking at dividend growth, the company's current annualized dividend of $1.10 is up 1.4% from last year. Over the last 5 years, Avient has increased its dividend 5 times on a year-over-year basis for an average annual increase of 6.00%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Avient's current payout ratio is 38%, meaning it paid out 38% of its trailing 12-month EPS as dividend.
Looking at this fiscal year, AVNT expects solid earnings growth. The Zacks Consensus Estimate for 2026 is $3.08 per share, representing a year-over-year earnings growth rate of 9.22%.
Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. However, not all companies offer a quarterly payout.
Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, AVNT presents a compelling investment opportunity; it's not only an attractive dividend play, but the stock also boasts a strong Zacks Rank of #2 (Buy).
Avient (AVNT - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.
Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.
As such, the Zacks rating upgrade for Avient is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
For Avient, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.
Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for AvientFor the fiscal year ending December 2026, this maker of resins used in plastic pipe and other products is expected to earn $3.08 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for Avient. Over the past three months, the Zacks Consensus Estimate for the company has increased 1.1%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Avient to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Store closures have become a common story in 2026. While food and restaurant chains like Five Guys, Pizza Hut, and Papa John’s tend to grab most of the headlines, this year has also seen closures from retail shopping brands like H&M and Glossier.
And now, another retailer is joining that list. Discount chain Dollar Tree Inc. has announced that it plans to close around 75 stores, even as it grows its overall footprint. Here’s what you need to know.
Dollar Tree to shutter 75 locationsDollar Tree is celebrating its 40th anniversary this year. But unfortunately, its 40th will also be marked by store closures.
On May 28, Dollar Tree reported its first-quarter fiscal 2026 results, which ended on May 2. Overall, those results were healthy. The chain reported net sales of $5 billion, an increase of 7.2% over the same quarter a year earlier. Its adjusted diluted earnings per share (EPS) also grew 38.1% to $1.74.
Subscribe to the Daily newsletter.Fast Company's trending stories delivered to you every day
During the same quarter, the company also opened 113 new Dollar Tree stores, bringing its total to 9,382 stores across the U.S. and Canada.
However, the company also announced that it would be closing some locations in fiscal 2026, which ends in January. Specifically, Dollar Tree said it will close approximately 75 locations during its current fiscal year.
While that number seems high, it represents less than 1% of all Dollar Tree stores.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Hub Group, Inc. (NASDAQ: HUBG) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Hub Group securities between April 28, 2023 and May 11, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/HUBG.
Hub Group Case Details
The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
(1) Hub Group's financial statements prepared for the periods from Q1 2023 to Q4 2024, including its annual reports for 2023 and 2024, contained material misstatements caused by the premature and incorrect recognition of certain transactions concerning, among other things, the Company's operating revenue, operating income, revenue recognition, effectiveness of internal controls and procedures, and drivers of financial results and growth;
(2) Hub Group's financial statements prepared for the periods from Q1 2025 to Q3 2025 contained material misstatements caused by the understatement of purchased transportation costs and accounts payable concerning, among other things, the Company's operating expenses, purchased transportation and warehousing expenses, operating income, effectiveness of internal disclosure controls and procedures, and drivers of financial results and growth; and
(3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects lacked a reasonable basis and were materially false and misleading at all relevant times.
What's Next for Hub Group Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/HUBG. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Hub Group you have until August 28, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to Hub Group Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Hub Group Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hub Group, Inc. (“Hub Group” or the “Company”) (NASDAQ: HUBG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether Hub Group and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until August 28, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Hub Group securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
[Click here for information about joining the class action]
On February 5, 2026, Hub Group announced that the Company’s financial statements for the first three quarters of 2025 should not be relied upon due to “an error that resulted in the understatement of purchased transportation costs and accounts payable in the first nine months of 2025.” The Company revealed that its reports for those quarters “were in each case materially misstated due to the aforementioned error and should no longer be relied upon” and that “the Company [wa]s also continuing to assess the effectiveness of its disclosure controls and procedures and internal control over financial reporting and appropriate remediation steps.” The Company also estimated that “[t]he total amount of the reduction to accounts payable and purchased transportation costs related to this issue that was recorded during these periods is $77 million.” As such, Hub Group stated that it “plans to restate its financial statements for the first, second and third quarters of 2025.”
On this news, Hub Group’s stock price fell $9.37 per share, or 18.25%, to close at $41.96 per share on February 6, 2026.
Then, on May 12, 2026, Hub Group announced that it had “identified certain transactions that were prematurely or incorrectly recognized or not adequately supported,” causing its 2023 and 2024 annual reports filed with the SEC to be “materially misstated,” such that they “should no longer be relied upon.” The Company did not quantify the expected misstatement, although it “expect[ed] to conclude that it did not maintain effective disclosure controls and procedures and internal control over financial reporting for each of the years ended December 31, 2024 and 2023.”
On this news, Hub Group’s stock price fell $5.24 per share, or 12.52%, to close at $36.62 per share on May 12, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of purchasers of securities of Hub Group, Inc. (NASDAQ: HUBG) between April 28, 2023 and May 11, 2026, inclusive (the “Class Period”), of the important August 28, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Hub Group securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Hub Group class action, go to https://rosenlegal.com/cases/hub-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that Hub Group’s financial statements prepared for the periods from Q1 2023 to Q4 2024, including annual reports for 2023 and 2024, contained material misstatements—caused by the premature and incorrect recognition of certain transactions—concerning, inter alia, Hub Group’s operating revenue, operating income, revenue recognition, effectiveness of internal controls and procedures, and drivers of financial results and growth. In addition, Hub Group’s financial statements prepared for the periods from Q1 2025 to Q3 2025 contained material misstatements—caused by the understatement of purchased transportation costs and accounts payable —concerning, inter alia, Hub Group’s operating expenses, purchased transportation and warehousing expenses, operating income, effectiveness of internal disclosure controls and procedures, and drivers of financial results and growth. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Hub Group class action, go to https://rosenlegal.com/cases/hub-group-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827 [email protected]
www.rosenlegal.com
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Insulet Corporation (“Insulet” or the “Company”) (NASDAQ: PODD) and certain officers. The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 26-cv-13062, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Insulet securities between February 21, 2025 and May 26, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
If you are an investor who purchased or otherwise acquired Insulet securities during the Class Period, you have until August 31, 2026, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
[Click here for information about joining the class action]
Insulet develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States (“U.S.”) and internationally.
The Company offers, inter alia, its “Omnipod 5” automated insulin delivery (“AID”) system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and its “Omnipod Dash”, which features a Bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager.
Insulet also formerly offered the Omnipod Insulin Management System, its predecessor to the Omnipod 5, prior to the Class Period, but had already begun to phase out the product by the start of the Class Period.
The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Insulet’s manufacturing controls and procedures were defective; (ii) the foregoing created a foreseeable heightened risk that one or more Insulet products would be found to be in violation of applicable safety regulations and/or pose a risk of injury; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times.
The truth began to emerge on March 12, 2026, when Insulet disclosed that it had “initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods after identifying a manufacturing issue through its ongoing product monitoring.”
On this news, Insulet’s stock price fell $16.23 per share, or 6.88%, to close at $219.84 per share on March 13, 2026.
Then, on May 26, 2026, Insulet disclosed the “initat[ion]” of another “voluntary Medical Device Correction”, this time “for specific lots of Omnipod® 5, Omnipod Dash®, and Omnipod® Insulin Management System (Omnipod Eros) Pods due to a manufacturing issue, identified through ongoing product monitoring, that could result in insulin under-delivery.”
On this news, Insulet’s stock price fell $7.79 per share, or 5.07%, to close at $146.01 per share on May 27, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether HCA and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 14, 2026, HCA issued a press release reporting its preliminary financial and operating results for the second quarter of 2026. Among other items, HCA sharply lowered its full-2026 profit guidance, citing an unfavorable shift in the Company’s payer mix, which impacted revenue by approximately $400 million in the quarter.
On this news, HCA’s stock price fell $27.14 per share, or 6.95%, to close at $363.60 per share on July 14, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Ensign Group, Inc. (“Ensign Group” or the “Company”) (NASDAQ: ENSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Ensign Group and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On June 8, 2026, Hunterbrook published a short report alleging that Ensign Group’s business model relies on inadequate patient care and gaming quality metrics. The Hunterbrook report further alleges that Ensign Group’s profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates, and that patients have suffered and died as a result.
Following publication of the Hunterbrook report, Ensign Group’s stock price fell $13.88 per share, or 8.15%, to close at $156.42 per share on June 8, 2026.
Then, on June 11, 2026, Muddy Waters Research published a short report on Ensign Group, alleging possible Medicare and Medicaid fraud via a scheme to rent licenses of administrators of skilled nursing facilities who are not actually managing the facilities, potentially in violation of the False Claims Act.
Following publication of the Muddy Waters report, Ensign’s stock price fell $4.52 per share, or 2.98%, to close at $147.13 per share on June 11, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether AppLovin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 13, 2026, a Bank of America Securities analyst published a note reporting softer-than-expected e-commerce ad growth for the month of June, raising concerns over the rollout of AppLovin’s new AI-driven merchant platform.
Following publication of the note, AppLovin’s stock price fell $64.13 per share, or 12.65%, to close at $442.85 per share on July 13, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Key Takeaways Ameriprise is expected to report higher Q2 earnings and revenues, with results due on July 23.AMP's management, advice and distribution fees are projected to rise as total AUM and AUA grow.Ameriprise's technology upgrades and hiring are expected to lift costs despite ongoing cost management. Ameriprise Financial, Inc. (AMP - Free Report) is slated to announce second-quarter 2026 results on July 23, before market open. Its quarterly revenues and earnings are expected to have risen year over year.
In the last reported quarter, AMP’s earnings beat the Zacks Consensus Estimate. An increase in revenues, and higher assets under management (AUM) and assets under administration (AUA) balances acted as tailwinds. Conversely, an increase in expenses was a headwind.
Ameriprise has an impressive earnings surprise history. Its earnings surpassed the Zacks Consensus Estimate in the trailing four quarters, the average beat being 5.1%.
Q2 Estimates & Key Factors to Note for AmeripriseThe Zacks Consensus Estimate for AMP’s management and financial advice fees (constituting more than 60% of total net revenues) is pegged at $2.98 billion, suggesting a 14.6% rise from the prior-year quarter’s reported number.
The consensus estimate for distribution fees of $579 million indicates a year-over-year increase of 15.3%. The consensus mark for other revenues of $149 million suggests 9.6% growth.
The consensus estimate for premiums, policy and contract charges is pegged at $368 million, implying a year-over-year rise of 1.9%.
Alternatively, the consensus estimate for net investment income of $819 million suggests a year-over-year decline of 8.1%.
Decent inflows are expected to have driven the company’s total AUM and AUA balance. The Zacks Consensus Estimate for total AUM and AUA is pegged at $1.72 trillion, indicating a rise of 8.4% from the year-ago quarter’s actual.
While Ameriprise’s initiatives to focus on cost management have led to controlled general and administration expenses, overall costs are anticipated to have been elevated in the to-be-reported quarter due to those related to technology upgrades and hirings.
Earnings Whispers for AmeripriseOur proven model cannot conclusively predict an earnings beat for Ameriprise this time around. This is because it does not have the right combination of the two key ingredients — a positive Earnings ESP and a Zacks Rank #3 (Hold) or better, which is required to be confident of an earnings surprise call.
You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Earnings ESP: Ameriprise has an Earnings ESP of 0.00%.
Zacks Rank: The company currently carries a Zacks Rank #2 (Buy).
Ameriprise’s Q2 Earnings & Sales EstimatesThe Zacks Consensus Estimate for the company’s quarterly earnings is pegged at $10.72 per share, which indicates a rise of 17.7% from the prior-year quarter’s actual. The consensus estimate has been unchanged over the past seven days.
The consensus estimate for total quarterly sales is pegged at $4.79 billion, which suggests a 10.5% year-over-year increase.
Finance Stocks Worth a LookHere are a couple of finance stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time:
The Earnings ESP for Moody's Corporation (MCO - Free Report) is +1.36% and it currently carries a Zacks Rank #2. The company is slated to report quarterly results on July 22. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Over the past seven days, the Zacks Consensus Estimate for Moody’s quarterly earnings has been unchanged at $4.23.
Blackstone (BX - Free Report) is scheduled to report quarterly results on July 23. The company has an Earnings ESP of +0.16% and a Zacks Rank #3.
Over the past seven days, the Zacks Consensus Estimate for Blackstone’s quarterly earnings has been revised lower to $1.31.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Shares of Super Micro Computer (NASDAQ:SMCI | SMCI Price Prediction), Dell Technologies (NYSE:DELL), and Hewlett Packard Enterprise (NYSE:HPE) are all rallying Tuesday midday as AI hardware names ride a broad market rebound. Super Micro Computer stock is up 6% to $25.23, Dell stock is up 7% to $406.60, and HPE stock is up 5% to $46.76.
The move comes as the NASDAQ 100 climbs 1.88% on easing U.S.-Iran tensions and renewed deal hopes, extending this week’s rebound in AI and chip hardware names. No fresh company-specific catalyst is a main driver for today’s rally in Super Micro Computer, Dell, or HPE. These are high-beta AI server proxies, and they tend to amplify broad-market moves in both directions.
Each of the three names entered Tuesday’s session under recent pressure, so today’s bounce reclaims some lost ground for the trio. Traders are treating Super Micro Computer, Dell, and HPE as a single AI infrastructure trade, with the tickers moving in lockstep on macro headlines rather than fundamentals.
AI Hardware Names Ride the NASDAQ Rally Investors are treating Super Micro Computer, Dell, and HPE as leveraged proxies for AI infrastructure spend. When enterprise AI demand looks intact and macro fears ease, these names rip together. The NASDAQ’s near-2% jump today, driven by geopolitics rather than any single earnings report, is exactly the kind of session that lifts them as a group.
Dell’s fundamental backdrop remains supportive. The company booked $24.4 billion in AI orders in Q1 FY27 and raised full-year revenue guidance to $165 billion to $169 billion, calling for full-year AI server revenue near $60 billion. Furthermore, HPE reported Q2 FY26 revenue of $10.68 billion, up 40% year over year (YoY), with the Juniper Networks integration lifting networking revenue 148%.
Meanwhile, Super Micro Computer’s most recent quarter was mixed. The company’s Q3 FY26 revenue landed at $10.24 billion, up 123% YoY but well short of the $12.45 billion Street estimate, though Super Micro Computer’s non-GAAP EPS of $0.84 beat the $0.62 consensus.
A Tale of Three YTD Stories Looking at 2026 so far, Dell shares are up by a whopping 223% year to date (YTD) with a trailing P/E ratio of 32x, while HPE shares are up 95% YTD with a P/E ratio of 44x. Super Micro Computer shares, even including today’s pop, remain down 14% YTD, trading at a P/E ratio of 13x.
Dell and HPE sit among 2026’s biggest AI hardware winners. Super Micro Computer badly lags. The open question is whether Super Micro Computer is a genuine bargain at 13x earnings or a value trap.
The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.
Super Micro Computer’s issues shouldn’t be overlooked. A $7 billion financing meant to fund a roughly $39 billion AI-server backlog raises dilution risk, and an independent board review on export-control matters adds governance uncertainty.
HPE’s 44x multiple looks somewhat rich for a legacy hardware franchise, though the Juniper deal and a free cash flow guide of at least $3.5 billion for FY26 give bulls cover. Dell’s 32x sits in the middle, reflecting a market that has already awarded the stock significant AI credit.
HPE Networking Push and an ETF Angle HPE and GTT Communications announced today an expanded Secure Access Service Edge (SASE) managed services partnership built on HPE Aruba and EdgeConnect. It’s a minor business item unrelated to today’s 5% move in HPE stock, though it does reinforce the networking angle that has been a quiet driver for HPE’s Juniper-boosted segment.
Investors seeking AI hardware exposure without single-stock risk can consider the iShares U.S. Technology ETF (NYSEARCA:IYW). The fund is up roughly 2% today and 21% YTD to $244.50. IYW holds all three names at small weights but is heavily concentrated in mega-caps like NVIDIA (NASDAQ:NVDA), which alone accounts for 16% of the fund.
IYW offers a diversified, somewhat de-risked way to play the AI hardware theme. The ETF isn’t leveraged, and it dilutes the volatility that comes with owning Super Micro Computer or Dell shares outright. It won’t track the trio tightly, given the fund’s top-heavy composition.
What to Watch Traders can watch for whether today’s gains hold into the close, particularly for Super Micro Computer shares, which need sustained momentum to reclaim the 2026 breakeven line. Any softening in the geopolitical backdrop could quickly unwind the day’s move given how tightly these names track macro sentiment.
The next scheduled catalysts are earnings reports. Super Micro Computer has guided Q4 FY26 revenue to $11 billion to $12.5 billion, and that report will be the real test of whether 13x earnings is a floor or a warning. Dell and HPE both report next in late summer, and those calls could reset the AI hardware narrative for the back half of the year.
If You'd Bought Amazon When the Motley Fool Said To…In September 2002, Stock Advisor told subscribers to buy Amazon. In December 2004, Netflix. In April 2005, Nvidia. The newsletter still publishes two new stock picks every month — and over 23 years, has more than quadrupled the S&P 500. Here's how to get this month's picks:
- Join Stock Advisor for one year, with a 30-day money-back guarantee
- Get this month's two new picks — plus the Top 10 Rankings and the full historical pick list
- Read the analysis, decide for yourself, and trade through your own brokerage
Five years from now, you'll probably wish you'd bought this month's picks. Don't miss them.
Bloom Energy (BE +16.46%) stock snapped out of its recent slump this morning, jumping 14% as of 12:05 p.m. ET Tuesday.
While shares of the fuel cell maker had taken a breather in recent weeks following its massive 248% run in the first half of 2026, at least one analyst believes now's the time to buy, predicting shares could surge another 75% from current levels.
Image source: Getty Images.
Why analysts expect Bloom Energy stock to soar In a fresh note to investors, JP Morgan analyst Mark Strouse raised Bloom Energy stock's price target to $346 per share from $267 a share. That's an almost 75% upside from the stock's Monday closing price.
Strouse projects Bloom Energy could deliver 4.1 gigawatts (GW) of fuel capacity in fiscal year 2030, driven by aggressive demand from tech companies desperate for immediate, off-grid power to start their data centers.
Bloom Energy's recent contracts are central to JP Morgan's massive projection, especially its deepening ties with Brookfield Asset Management.
Today's Change
(
16.46
%) $
32.44
Current Price
$
229.50
What began as a $5 billion deal between the fuel-cell expert and asset management giant to power AI data centers has now expanded fivefold into a $25 billion mega-partnership, reflecting a colossal appetite from hyperscalers who need clean, reliable electricity online long before traditional utility grids can deliver it.
Should you buy Bloom Energy stock before July 28? Given the severe AI power crunch and Bloom Energy's proven track record, two outcomes seem almost inevitable in the near term: a steady drumbeat of new contract announcements and another set of bumper numbers when it reports its second-quarter earnings on July 28 after market close.
Last quarter, management raised its full-year revenue growth guidance from around 60% to around 80% at the midpoint. That's phenomenal growth for a company operating at this scale.
So is the stock a buy now? While jumping right before earnings is a speculative move, Bloom Energy isn't a speculative stock. It has positioned itself for the AI power boom, setting itself up way ahead of the competition to exploit the market.
Multi-billion-dollar contracts, a soaring backlog, and expanding high-margin product sales makes Bloom Energy stock a rock-solid buy on dips for the long term, not just one earnings report.
JPMorgan Chase is an advertising partner of Motley Fool Money. Neha Chamaria has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bloom Energy, Brookfield Asset Management, and JPMorgan Chase. The Motley Fool has a disclosure policy.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of FirstSun Capital Bancorp (“FirstSun” or the “Company”) (NASDAQ: FSUN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether FirstSun and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On July 9, 2026, FirstSun disclosed that it “expect[s] charge-offs to average loans to be in the high 50s range in basis points” and projected a $40 million to $41 million provision for credit losses and $42 million to $43 million in charge-offs, including a $22 million charge-off tied to a suspected-fraud loan.
On this news, FirstSun’s stock price fell $2.85 per share, or 7.5%, to close at $35.08 per share on July 10, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Atlantic Union Bankshares delivered a strong Q2, with 6% sequential revenue growth and robust net interest margins at 3.89%. Loan and deposit growth remained steady, with loans at $28.67 billion and deposits at $30.47 billion, reflecting consistent balance sheet expansion. Credit quality stayed solid, with net charge-offs at just 0.03% of loans and allowance for credit losses steady at 1.15%.
Key Takeaways Acadia received FDA Fast Track designation for remlifanserin in Alzheimer's disease psychosis. ACAD expects phase II top-line data between September and October 2026 as phase III enrollment continues. Acadia expects Nuplazid and Daybue combined net sales of about $1.7 billion by 2028. Acadia Pharmaceuticals (ACAD - Free Report) announced that the FDA has granted Fast Track designation to its investigational, highly selective, 5-HT2A receptor inverse agonist, remlifanserin, for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP).
The FDA’s Fast Track designation is intended to expedite the development and review of drugs that treat serious conditions and fulfill unmet medical needs to get important new drugs to patients earlier. It offers benefits, such as more frequent FDA interactions, rolling submission of marketing applications and potential eligibility for Priority Review if certain conditions are met.
According to Acadia, there are currently no FDA-approved therapies for treating ADP.
More on ACAD’s RemlifanserinClinical Development ProgramAcadia is currently evaluating the safety and efficacy of remlifanserin in the RADIANT development program for the treatment of hallucinations and delusions associated with ADP. The company has completed enrollment in the phase II portion of the program and now expects to report top-line results between September and October 2026. Meanwhile, in line with the RADIANT program's seamless operational design, screening and patient enrollment are already underway for the phase III studies. In 2025, ACAD initiated another phase II study of remlifanserin for a second indication – Lewy Body Dementia with Psychosis.
Year to date, ACAD shares have lost 6% against the industry’s 2.4% growth.
Image Source: Zacks Investment Research
Apart from remlifanserin, Acadia’s clinical pipeline comprises several other candidates. The company, in partnership with Saniona, is gearing up to initiate a mid-stage study of ACP-711 for essential tremor in late 2026. In late 2025, ACAD initiated a mid-stage study of ACP-211 for the treatment of major depressive disorder. A first-in-human study of ACP-271 in healthy volunteers was also initiated in the first quarter of 2026.
ACAD's Marketed Drugs Expected to Aid GrowthAcadia’s long-term growth is supported by its lead product, Nuplazid and Daybue, in the United States. The company expects to generate around $1.7 billion in combined net sales by 2028, including $1 billion for Nuplazid and $700 million for Daybue.
Nuplazid is the first and only FDA-approved treatment for hallucinations and delusions associated with Parkinson’s disease psychosis in the United States. The drug enjoys patent protection in the United States until 2038, giving it a long runway for revenue generation by protecting against generic erosion. In the first quarter of 2026, Nuplazid recorded $167 million in sales, up 5% year over year, driven primarily by volume growth.
Since its U.S. launch in 2023 as the first and only treatment for Rett syndrome in adults and pediatric patients aged two years and older, Daybue has witnessed encouraging sales uptake. In the first quarter of 2026, Daybue recorded $101 million in sales, up 20% year over year, driven by growth in the drug’s unit sales as Acadia shipped it to more unique patients. A similar filing is also currently under regulatory review in the EU. A potential nod could further boost sales. Daybue is also marketed (and available) in Canada and Israel for the same indication.
In late 2025, the FDA approved Daybue Stix (trofinetide), a dye- and preservative-free powder formulation for the treatment of Rett syndrome in adults and pediatric patients aged two years and older. The new product expands the Daybue franchise, which remains the only FDA-approved treatment option for this indication.
Daybue Stix is now broadly available in the United States. The company will continue to offer the current oral solution alongside the new formulation, strengthening its positioning in the Rett syndrome treatment market.
ACAD's Zacks Rank & Stocks to ConsiderAcadia currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the biotech sector are Neurocrine Biosciences (NBIX - Free Report) , Amarin Corporation (AMRN - Free Report) and Liquidia Corporation (LQDA - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past 60 days, estimates for Neurocrine Biosciences’ 2026 earnings per share have risen from $9.15 to $9.44. Over the same period, EPS estimates for 2027 have increased from $10.23 to $10.79. NBIX shares have gained 22% year to date.
Neurocrine Biosciences’ earnings beat estimates in three of the trailing four quarters and missed in the remaining one, the average surprise being 9.08%.
Over the past 60 days, loss per share estimates for Amarin have narrowed from $6.36 to 65 cents for 2026. Over the same period, estimates for loss per share have also narrowed from $4.64 to 51 cents for 2027. AMRN shares have lost 2.5% year to date.
Amarin’s earnings beat estimates in three of the trailing four quarters and missed in the remaining one, the average surprise being 50.02%.
Over the past 60 days, estimates for Liquidia’s 2026 earnings per share have increased to $3.02 from $2.97. Over the same period, EPS estimates for 2027 have risen to $4.92 from $4.81. LQDA shares have soared 123.5% year to date.
Liquidia’s earnings beat estimates in three of the trailing four quarters and missed in the remaining one, the average surprise being 54.40%.
Key Takeaways Crown Holdings posted Q2 adjusted EPS of $2.49 as global beverage can volumes rose 5%.CCK raised its 2026 adjusted EPS guidance to $8.30-$8.50 from the prior $7.90-$8.30.Crown Holdings repurchased more than $500 million in shares in the first half of 2026. Crown Holdings, Inc. (CCK - Free Report) reported second-quarter 2026 adjusted earnings of $2.49 per share, up 15.8% year over year. The figure surpassed the Zacks Consensus Estimate of $2.15 by 15.81%.
Including one-time items, the company reported earnings of $2.23 per share in the quarter under review compared with $1.56 in second-quarter 2025.
Net sales increased 16.5% to $3.67 billion and beat the consensus estimate of $3.34 billion by 9.88%. Global beverage can volumes rose 5%, led by 6% growth in Europe and 5% growth in the Americas. This was partially offset by softer demand in Latin America.
Crown Holdings’ Q2 Gross Profit Rises Y/YThe cost of products sold rose 19.9% year over year to $2.92 billion. On a year-over-year basis, gross profit moved up 4.9% to $748 million. The gross margin declined to 20.4% from the year-ago quarter’s 22.6%.
Selling and administrative expenses rose 3.1% year over year to $166 million. Segmental operating income was $501 million compared with the prior-year quarter’s $476 million.
CCK’s Segment Performances in Q2Net sales in the Americas Beverage segment totaled $1.7 billion, up 20.1% year over year. The improvement reflected higher beverage can volumes and favorable currency translation. Segmental operating profit decreased 1.1% year over year to $265 million.
The European Beverage segment’s sales rose 15.7% year over year to $735 million. Operating income was $107 million compared with the year-ago quarter’s $97 million. The upside was supported by higher shipments and improved operating performance across the region.
The Asia-Pacific segment’s revenues totaled $331 million, up 29.3% year over year. Operating profit was $53 million compared with the prior-year quarter’s $50 million.
Revenues in the Transit Packaging segment totaled $537 million compared with the year-ago quarter’s $526 million. Operating profit fell 5.6% year over year to $68 million as weakness in global industrial markets continued to weigh on performance.
Crown Holdings’ Cash Flow & Balance Sheet UpdatesCCK had cash and cash equivalents of $0.66 billion at the end of second-quarter 2026, down from $0.94 billion at the end of the prior-year quarter. The company generated $659 million in cash from operating activities in the first half of 2026 compared with $463 million in the year-ago comparable period.
Crown Holdings’ long-term debt decreased to $5.50 billion as of June 30, 2026, from $5.62 billion as of June 30, 2025.
The company repurchased $305 million of common stock during the second quarter. Total repurchases exceeded $500 million in the first six months of 2026 and represented roughly 7% of outstanding shares.
The company emphasized its confidence in long-term cash flow generation while maintaining balance-sheet flexibility. Dividends paid out to shareholders totaled $77 million during the first half, up from $60 million in the prior-year period.
CCK Raises 2026 EPS OutlookCrown Holdings increased its full-year adjusted earnings guidance to $8.30-$8.50 per share from the prior mentioned $7.90-$8.30. The midpoint of $8.40 implies growth of 10.7% from adjusted earnings of $7.59 in 2025.
For the third quarter, CCK expects adjusted earnings of $2.20-$2.30 per share. It also projects adjusted free cash flow of at least $900 million, with a capital expenditure of $550 million.
The company expects beverage can demand to remain strong through the balance of the year. It highlighted continued momentum in Europe and North America, along with improving market conditions in Brazil.
Crown Holdings Stock’s Price PerformanceThe company’s shares have gained 10.8% in the past year compared with the industry’s 5.8% growth.
Image Source: Zacks Investment Research
CCK’s Zacks RankCrown Holdings currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Packaging Products Stocks Awaiting ResultsBall Corporation (BALL - Free Report) is scheduled to release second-quarter 2026 results on Aug. 4. The Zacks Consensus Estimate for BALL’s second-quarter 2026 earnings is pegged at 99 cents per share, suggesting year-over-year growth of 10%.
The Zacks Consensus Estimate for Ball Corp’s top line is pegged at $3.67 billion, indicating growth of 9.8% from the prior-year reported figure. Ball Corp has a trailing four-quarter average surprise of 3.7%.
Silgan Holdings Inc. (SLGN - Free Report) is scheduled to release second-quarter 2026 results on July 29. The Zacks Consensus Estimate for SLGN’s second-quarter 2026 earnings is pegged at 96 cents per share, implying a year-over-year dip of 4.9%.
The Zacks Consensus Estimate for Silgan Holdings’ top line is pegged at $1.62 billion, suggesting an increase of 5.1% from the prior-year reported figure. Silgan Holdings has a trailing four-quarter average surprise of 1.8%.
AptarGroup, Inc. (ATR - Free Report) is scheduled to release second-quarter 2026 results on July 30. The Zacks Consensus Estimate for AptarGroup’s second-quarter 2026 earnings is pegged at $1.34 per share, indicating a year-over-year dip of 19.3%.
The Zacks Consensus Estimate for the company’s top line is pegged at $1 billion, implying growth of 3.8% from the prior-year reported figure. ATR has a trailing four-quarter average surprise of 3.1%.
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.
That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.
Vistra Corp. (VST - Free Report) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.
Studies have shown that stocks with the best growth features consistently outperform the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.
Here are three of the most important factors that make the stock of this company a great growth pick right now.
Earnings GrowthEarnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for Vistra is 44.7%, investors should actually focus on the projected growth. The company's EPS is expected to grow 81.1% this year, crushing the industry average, which calls for EPS growth of 6.9%.
Impressive Asset Utilization RatioGrowth investors often overlook asset utilization ratio, also known as sales-to-total-assets (S/TA) ratio, but it is an important feature of a real growth stock. This metric shows how efficiently a firm is utilizing its assets to generate sales.
Right now, Vistra has an S/TA ratio of 0.49, which means that the company gets $0.49 in sales for each dollar in assets. Comparing this to the industry average of 0.22, it can be said that the company is more efficient.
While the level of efficiency in generating sales matters a lot, so does the sales growth of a company. And Vistra is well positioned from a sales growth perspective too. The company's sales are expected to grow 34.5% this year versus the industry average of 4.7%.
Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
The current-year earnings estimates for Vistra have been revising upward. The Zacks Consensus Estimate for the current year has surged 2.3% over the past month.
Bottom LineWhile the overall earnings estimate revisions have made Vistra a Zacks Rank #1 stock, it has earned itself a Growth Score of B based on a number of factors, including the ones discussed above.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination positions Vistra well for outperformance, so growth investors may want to bet on it.
One of the better ways for income investors to profit from the energy sector is by snapping up shares of a pipeline company. And one of the more appealing pipeline plays is Energy Transfer (ET +0.00%), which transports crude oil and its refined products, plus natural gas.
Energy Transfer is structured as a master limited partnership (MLP). A great benefit of owning units (not shares) in an MLP is the high-yield distributions -- i.e., dividends -- they tend to pay. Sure enough, Energy Transfer's payout is generous enough to generate $1,000 in annual income with relatively few units.
Image source: Getty Images.
Energy Transfer? More like a wealth transfer to investors Energy Transfer currently doles out a quarterly distribution of just under $0.34 per unit. This annualizes to $1.35 -- for a lofty yield of 6.6% -- so an investor needs to hold 741 units to hit the $1,000-per-year mark. That would set you back $15,057 and a little change at the most recent closing unit price.
Why such a high yield, you might ask? That's because an MLP doesn't pay federal income taxes; rather, it's a "pass-through" entity in which, yes, that obligation is passed through to investors. This frees what can be significant amounts of cash for investor-pleasing items like distributions.
There are strict parameters for being an MLP. Such a business must derive at least 90% of its gross income from qualifying sources. In the energy sector, that means the exploration, production, or transportation of energy products.
Today's Change
(
0.00
%) $
0.00
Current Price
$
20.28
Size matters In terms of size, Energy Transfer is the No. 1 energy pipeline operator in the U.S., boasting around 140,000 miles over 44 states. This network is plugged into major oil and gas plays such as the massive Permian Basin in the Southwest.
That size and reach make Energy Transfer a go-to partner for energy companies that need to move product across this country.
The MLP charges fixed fees for the service, making it -- somewhat atypically for the energy sector -- not dependent on the prices of the goods being transported. As such, it can be something of a hedge for falling prices.
In periods of abundance, Energy Transfer frequently dips into the market, buying and selling some of the product it transports. So revenue and profitability can be a bit up and down -- for example, in 2022, its annual top line was almost $90 billion but fell below $79 billion the following year. Then it rose in both 2024 and 2025, landing at $85.5 billion in the latter year.
Ditto for free cash flow (FCF). Since 2022, it has ranged from $3.9 billion to almost $6.5 billion annually, and is usually more than enough to finance the distribution.
Which, by the way, typically gets a marginal (albeit very reliable) raise every single quarter. Since Energy Transfer began paying its quarterly distribution in 2006, it has risen steadily to the current level. Management has indicated that it aims to keep growth at 3% to 5% annually.
The power of the payout It's been mission accomplished thus far, so I think it'll be able to hit that goal in the coming quarters and years. Energy Transfer always thrives and is laser-focused on delivering what income investors most want. The MLP is an excellent dividend -- sorry, distribution -- equity to own.
Key Takeaways WTI trades above $80 as Middle East conflicts intensify, supporting upstream activity.Patterson-UTI could benefit as producers increase drilling and completion work.TechnipFMC may gain from rising demand across Subsea and Surface Technologies. Oil prices are climbing again as the Iran war intensifies. This is creating opportunities for investors willing to allocate capital to the oil-energy space that has witnessed a strong rally of 30.6% over the past year, outperforming the Zacks S&P 500 composite’s increase of 21%. Given the favorable backdrop, should investors bet on Patterson-UTI (PTEN - Free Report) and TechnipFMC (FTI - Free Report) ? Let’s dive in.
Image Source: Zacks Investment Research
High Oil PriceWest Texas Intermediate (“WTI”) oil is currently trading above $80 per barrel, according to data from Oilprice.com, significantly higher than the shut-in prices for existing wells in key resources. The escalation of Middle East conflicts has been aiding the rally in commodity prices.
In its latest short-term energy outlook, the EIA projects the WTI spot price to average $76.26 per barrel this year, a level that should remain supportive of upstream operations, as many producers have considerably lower breakeven costs. With higher exploration and production activities, demand for oilfield services and drilling activities is also expected to improve.
2 Energy Stocks to Bet on: PTEN, FTIPatterson-UTI is expected to continue to gain from the prevailing crude-price scenario. This is because demand for the company’s drilling and completion services will likely remain robust, as the supportive commodity-price backdrop is expected to continue to bolster exploration and production operations. In other words, with increased exploration and production activities, upstream players will hire more drilling and completion services that will boost the bottom line of PTEN, which currently carries a Zacks Rank #2 (Buy).
TechnipFMC, being a leading provider of technology, equipment and services to the upstream players for extracting resources efficiently while reducing costs, is well-positioned to capitalize on the high oil prices. With exploration and production activities remaining favorable, demand for FTI’s services is likely to continue growing. With its activities spreading across Subsea and Surface Technologies, the company, with a Zacks Rank of 2, is strongly positioned to gain from both onshore and offshore operations. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways Comfort Systems' Q2 EPS is estimated to rise 59%, while revenues are projected to grow 35.4%.FIX's record backlog and data-center demand likely supported mechanical and electrical segment growth.Comfort Systems' margins likely benefited from project selection, pricing discipline and operating leverage. Comfort Systems USA, Inc. (FIX - Free Report) is slated to report its second-quarter 2026 results on July 23, after market close.
In the last reported quarter, the company’s earnings and revenues topped the Zacks Consensus Estimate by 46.2% and 18.1%, respectively. Adjusted earnings per share (EPS) of $10.51 grew a whopping 121.3% from $4.75 reported in the year-ago quarter. Revenues of $2.87 billion also increased 56.8% on a year-over-year basis.
FIX’s earnings topped the consensus mark in each of the trailing four quarters. The average surprise is shown in the chart below.
Image Source: Zacks Investment Research
How Are Estimates Placed for FIX Stock?The Zacks Consensus Estimate for second-quarter EPS has increased to $10.38 from $10.30 over the past 60 days. The estimate indicates 59% growth from the year-ago EPS of $6.53. The consensus mark for revenues is pegged at $2.94 billion, indicating a 35.4% year-over-year increase.
For 2025, Comfort Systems is expected to register a 30.6% increase from a year ago in revenues. Its EPS is expected to grow 49.2% from a year ago. Below is what to expect from the FIX stock.
Image Source: Zacks Investment Research
Image Source: Zacks Investment Research
Factors Likely to Have Defined FIX’s Q2 PerformanceStrong Backlog Likely Supported Revenues: Comfort Systems’ second-quarter 2026 revenues are expected to have remained robust, supported by continued execution of its record backlog and sustained demand from technology customers. Management indicated that data centers continue to dominate the company’s pipeline and backlog, providing strong revenue visibility entering the quarter. Demand from semiconductor manufacturing, industrial projects, healthcare, education and government markets is also likely to have supported project activity. The company’s nationwide footprint, expanding modular capabilities and strong execution across mechanical and electrical operations are expected to have further aided revenue conversion.
Segment-Wise: Comfort Systems operates through two main segments — Mechanical and Electrical. For second-quarter 2026, Comfort Systems’ Mechanical segment (which accounted for 73.3% of total revenues in 2025) is expected to have benefited from healthy demand for HVAC, piping, modular fabrication and process systems tied to data centers and advanced manufacturing projects. Continued investment in modular production capacity likely supported project execution. The Zacks Consensus Estimate for the segment’s revenues is currently pegged at $2.12 billion for the second quarter, up from $1.64 billion reported a year ago.
The Electrical segment (26.7%) is also expected to have delivered strong growth, driven by demand for power distribution and controls work associated with hyperscale data centers and other mission-critical facilities. The recently announced electrical acquisition is unlikely to have materially affected second-quarter results but should strengthen the business over time. The Zacks Consensus Estimate for the segment’s revenues is currently pegged at $800 million for the second quarter, up from $534.6 million reported a year ago.
Margins Likely Healthy: Margins are expected to have remained healthy in the second quarter. Management expects gross margins to stay within the strong ranges achieved in recent quarters, supported by disciplined project selection, favorable project execution, pricing discipline and operating leverage. Continued investments in modular manufacturing should enhance long-term efficiency, though labor availability remains the company's primary operational constraint rather than demand.
Overall, management did not issue specific second-quarter guidance but expressed confidence in the business outlook. It continues to expect full-year 2026 same-store revenue growth in the mid- to high-20% range, supported by persistent customer demand, strong bookings, expanding modular capacity and record backlog.
What the Zacks Model Says for FIX StockOur proven model does not conclusively predict an earnings beat for Comfort Systems this time around. A combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. This is not the case here.
FIX’s Earnings ESP: The company has an Earnings ESP of 0.00%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
FIX’s Zacks Rank: The company currently carries a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
FIX Stock’s Price PerformanceFIX stock has surged 83.4% year to date (YTD), outperforming the Zacks Building Products - Air Conditioner and Heating industry, the Construction sector and the S&P 500 Index.
FIX Stock’s Price Performance (YTD)
Image Source: Zacks Investment Research
Comfort Systems sits at a critical execution layer of the AI-driven data center and technology infrastructure boom, competing with Quanta Services, Inc. (PWR - Free Report) , Carrier Global Corp. (CARR - Free Report) and EMCOR Group, Inc. (EME - Free Report) across distinct but overlapping segments. So far this year, FIX has also outperformed these market players, of which Quanta and Carrier Global have gained 49.9% and 26.8%, respectively, while EMCOR has gained 21.6%. It has also comfortably exceeded the gains of these major peers, suggesting investors’ continued reward for Comfort Systems for its strong exposure to high-growth end markets, particularly AI data centers, advanced manufacturing and mission-critical infrastructure.
FIX’s Valuation TrendFIX stock is currently trading at a premium compared with the industry peers, with a forward 12-month price-to-earnings (P/E) ratio of 35.28, as evidenced by the chart below.
FIX’s Valuation vs Industry (P/E F12M)
Image Source: Zacks Investment Research
At 35.28x forward 12-month earnings, FIX trades above Carrier Global (22.42X) and EMCOR (23.74X), indicating investors are willing to pay a higher multiple for its superior growth outlook and execution. However, it is not the most expensive stock among the peer group, as Quanta commands an even richer multiple of 41.1X.
ConclusionDespite its premium valuation, Comfort Systems appears well positioned heading into its second-quarter results. The company continues to benefit from record backlog, robust demand from AI data centers, semiconductor and mission-critical infrastructure projects, healthy margins and favorable earnings estimate revisions. Its expanding modular manufacturing capabilities, disciplined project selection and strong same-store revenue growth outlook further reinforce confidence in its long-term growth trajectory. The company's industry-leading execution has also translated into significant stock outperformance versus both peers and the broader market, making FIX a stock investors should continue holding ahead of its second-quarter 2026 earnings release.
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at Apple Hospitality REIT (APLE - Free Report) , a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Apple Hospitality REIT currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market? In order to see if APLE is a promising momentum pick, let's examine some Momentum Style elements to see if this hotel-owning real estate investment trust holds up.
A good momentum benchmark for a stock is to look at its short-term price activity, as this can reflect both current interest and if buyers or sellers currently have the upper hand. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.
For APLE, shares are up 1.69% over the past week while the Zacks REIT and Equity Trust - Other industry is up 3.36% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 1.75% compares favorably with the industry's 4.3% performance as well.
While any stock can see a spike in price, it takes a real winner to consistently outperform the market. Over the past quarter, shares of Apple Hospitality REIT have risen 26.69%, and are up 36.95% in the last year. In comparison, the S&P 500 has only moved 4.95% and 19.48%, respectively.
Investors should also pay attention to APLE's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. APLE is currently averaging 2,891,326 shares for the last 20 days.
Earnings OutlookThe Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with APLE.
Over the past two months, 1 earnings estimate moved higher compared to none lower for the full year. This revision helped boost APLE's consensus estimate, increasing from $1.55 to $1.59 in the past 60 days. Looking at the next fiscal year, 1 estimate has moved upwards while there have been no downward revisions in the same time period.
Bottom LineTaking into account all of these elements, it should come as no surprise that APLE is a #2 (Buy) stock with a Momentum Score of B. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Apple Hospitality REIT on your short list.
LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming August 24, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Peabody Energy Corporation (“Peabody” or the “Company”) (NYSE: BTU) common stock between October 14, 2024 to May 4, 2026, inclusive (the “Class Period”).
IF YOU SUFFERED A LOSS ON YOUR PEABODY INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.
What Happened?
On March 30, 2026, Peabody issued a press release with lowered guidance concerning its Centurion mine’s first quarter 2026 output due to mining commissioning challenges.
On this news, Peabody’s stock price fell $3.82, or 9.7%, to close at $35.68 per share on March 30, 2026, thereby injuring investors.
Then, on May 5, 2026, Peabody disclosed that it had failed to complete its goal to fully ramp-up Centurion by March 2026 and that it was cutting guidance related to full year metallurgical segment volumes to reflect the increased cost and substantial volume decrease.
On this news, Peabody’s stock price fell $1.52, or 5.7%, to close at $25.00 per share on May 5, 2026, thereby injuring investors further.
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Peabody’s overly optimistic March 2026 Centurion ramp-up date and promises regarding the Company’s inflated guidance fell short of reality when numerous issues at Centurion caused a significant delay to the mine’s ramp-up and Peabody’s first quarter metallurgical segment volumes; and (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you purchased or otherwise acquired Peabody common stock during the Class Period, you may move the Court no later than August 24, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Peabody Energy Corporation (“Peabody” or the “Company”) (NYSE: BTU). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether Peabody and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You have until August 24, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Peabody securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.
[Click here for information about joining the class action]
On March 30, 2026, Peabody issued a press release lowering guidance pertaining to its Centurion mine’s expected first quarter 2026 output ahead of the Company’s full earnings release. Among other things, Peabody announced that sales volume from the Centurion mine was expected to deliver approximately 250,000 tons in the first quarter due to mining commissioning challenges (compared to previous estimates of around 700,000 tons).
On this news, Peabody’s stock price fell $3.82 per share, or 9.67%, to close at $35.68 per share on March 30, 2026.
Then, on May 5, 2026, Peabody issued a press release disclosing the Company’s failure to ramp-up output at the Centurion mine by the adverted-to March 2026 deadline and cutting guidance accordingly.
On this news, Peabody’s stock price fell $1.52 per share, or 5.73%, to close at $25.00 per share on May 5, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Key Takeaways Lamb Weston's quarterly revenues are likely to rise, supported by North America growth.Customer wins, market-share gains and an extra selling week are likely to lift North America volumes. Unfavorable price/mix and international weakness are likely to continue pressuring margins. Lamb Weston Holdings, Inc. (LW - Free Report) is likely to witness top-line growth when it reports fourth-quarter fiscal 2026 earnings on July 24. The Zacks Consensus Estimate for revenues is pegged at $1.7 billion, indicating an increase of 1.5% from the prior-year quarter’s reported figure.
The consensus mark for earnings has risen by a penny over the past 30 days to 62 cents a share, which suggests a decline of 28.7% from the figure reported in the year-ago period. LW has a trailing four-quarter surprise of 23.5%, on average.
Factors Likely to Influence LW’s Upcoming ResultsLamb Weston’s North America business is likely to have remained a key growth driver in the fiscal fourth quarter. Customer wins, market-share gains and strong retention, supported by a streamlined commercial strategy and deeper customer relationships, are expected to have aided volumes. Management projected high-single-digit North America volume growth for the second half of fiscal 2026, with the fourth quarter also benefiting from an additional selling week. Our model suggests a fourth-quarter volume increase of 4% for the North America segment.
The company’s Focus to Win strategy is also expected to have supported quarterly performance. Structural cost reductions, improving manufacturing productivity and disciplined capital deployment may have helped cushion inflationary and pricing pressures. Management noted that fiscal 2026 savings were running ahead of plan, while better operating efficiencies in North America are likely to have provided additional support.
Lamb Weston raised the lower end of its fiscal 2026 sales guidance to $6.45 billion, retained the upper end at $6.55 billion and narrowed its adjusted EBITDA outlook from $1-$1.2 billion to $1.08-$1.14 billion. The updated outlook, which incorporates favorable currency translation, an additional selling week, and anticipated tariff and Middle East-related impacts, signals management’s confidence heading into the fiscal fourth quarter.
However, price/mix is likely to have remained unfavorable despite expectations for pricing pressure to moderate following a March price increase. Continued customer trade support, value-oriented mix shifts, weak international traffic, excess European capacity and Middle East disruptions may have weighed on margins. We expect the adjusted gross margin to contract 210 basis points to 18.4% in the fourth quarter.
Earnings Whispers for LWOur proven model predicts an earnings beat for Lamb Weston this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is exactly the case here.
Lamb Weston currently carries a Zacks Rank #3 and has an Earnings ESP of +3.56%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Other Stocks With the Favorable CombinationHere are some other companies worth considering, as our model shows that these also have the right combination of elements to beat on earnings this reporting cycle.
Archer-Daniels-Midland Company (ADM - Free Report) currently has an Earnings ESP of +12.50% and a Zacks Rank of 2. The consensus estimate for ADM’s quarterly revenues is pinned at $22.4 billion, which calls for 5.7% growth from the figure reported in the prior-year quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Archer-Daniels’ upcoming quarter’s EPS is pegged at $1.28, which implies a 37.6% rise year over year. ADM delivered a trailing four-quarter earnings surprise of 5.4%, on average.
Kimberly-Clark Corporation (KMB - Free Report) currently has an Earnings ESP of +2.70% and a Zacks Rank of 3. The Zacks Consensus Estimate for Kimberly-Clark’s upcoming quarterly revenues is pegged at $4.2 billion. The figure implies a 1.7% increase from the prior-year quarter.
The Zacks Consensus Estimate for Kimberly-Clark’s quarterly earnings per share is pegged at $2.00, indicating a 4.2% gain from the year-ago period figure. KMB delivered a trailing four-quarter earnings surprise of 19.1%, on average.
Monster Beverage Corporation (MNST - Free Report) currently has an Earnings ESP of +0.45% and a Zacks Rank of 3. The consensus estimate for Monster Beverage’s quarterly revenues is pinned at $2.4 billion, which suggests 14.6% growth from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for the upcoming quarter’s EPS is pegged at 59 cents, which suggests a 13.5% jump year over year. MNST delivered a trailing four-quarter earnings surprise of 9.6%, on average.
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Logitech (LOGI - Free Report) . This company, which is in the Zacks Computer - Peripheral Equipment industry, shows potential for another earnings beat.
This maker of keyboards, webcams and other computer accessories has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 5.27%.
For the most recent quarter, Logitech was expected to post earnings of $1.1 per share, but it reported $1.13 per share instead, representing a surprise of 2.73%. For the previous quarter, the consensus estimate was $1.79 per share, while it actually produced $1.93 per share, a surprise of 7.82%.
Price and EPS Surprise
Thanks in part to this history, there has been a favorable change in earnings estimates for Logitech lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Logitech currently has an Earnings ESP of +1.35%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on July 28, 2026.
With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.
Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
HARTFORD, Conn. and BOSTON, July 21, 2026 (GLOBE NEWSWIRE) -- In recognition of its continued commitment to employees, operational excellence and long-term sustainability for customers, Eversource (NYSE: ES) has been named to TIME's list of America's Best Companies for 2026, a prestigious annual ranking presented by TIME and Statista that recognizes organizations based on employee satisfaction, financial performance and sustainability transparency that benefits customers.
"We're honored to be recognized by TIME as one of America's Best Companies because this award reflects the dedication of our thousands of employees who work every day to safely deliver reliable energy and exceptional service to our customers with an ever-present focus on affordability," said Eversource Chairman, President and Chief Executive Officer Joe Nolan. "Our people are the foundation of everything we do, and this recognition is a testament to their hard work and commitment. As we continue investing in our employees, we’ll remain focused on operating efficiently, keeping the costs we can control as low as possible and delivering safe and reliable service for our customers."
The TIME America's Best Companies 2026 ranking, presented in collaboration with Statista, evaluated companies across three key areas: employee satisfaction, financial performance and sustainability transparency. Employee satisfaction was measured through surveys of approximately 217,000 employees at U.S. companies over the past three years, while financial performance and sustainability transparency were assessed using a range of publicly available business and environmental, social and governance (ESG) metrics. The 1,000 highest-scoring companies earned a place on this year's list.
This latest recognition adds to Eversource's growing list of national honors for its customer-focused corporate responsibility, workplace excellence and sustainability, including being named one of Newsweek's America's Most Trustworthy Companies for 2026, one of Newsweek's America's Most Responsible Companies for 2026, and a VETS Indexes 5 Star Employer for 2026.
Eversource (NYSE: ES), celebrated as a national leader for its commitment to sustainability and corporate citizenship, is named among America’s Most Responsible Companies by Newsweek for 2026 and recognized as the #1 utility on USA Today’s list of America’s Climate Leaders for 2025. Eversource transmits and delivers electricity and natural gas to more than 4 million customers in Connecticut, Massachusetts and New Hampshire. The #1 Energy Efficiency Provider in the Nation, Eversource harnesses the commitment of more than 10,300 employees across three states to build a single, united company around the mission of safely delivering reliable energy with superior customer service. The company is empowering a clean energy future in the Northeast, with nationally recognized energy efficiency solutions and successful programs to integrate new clean energy resources like a first-in-the-nation networked geothermal pilot project, solar, offshore wind, electric vehicles and battery storage, into the electric system. For more information, please visit eversource.com, and follow us on X, Facebook, Instagram, and LinkedIn.
Key Takeaways CMCSA's Q2 outlook reflects fragile momentum as EPS and revenue are expected to decline year over year.CMCSA faces broadband losses, ARPU headwinds and intense fiber and fixed wireless competition.Peacock, media and theme parks face streaming costs, sports timing and travel headwinds. Comcast (CMCSA - Free Report) is scheduled to report its second-quarter 2026 results on July 23.
The Zacks Consensus Estimate for second-quarter earnings is pegged at 97 cents per share, down by a penny over the past 30 days. The figure indicates a 22.4% decrease from the year-ago quarter’s reported figure.
The consensus mark for revenues is pegged at $29.17 billion, indicating a 3.75% decrease from the year-ago quarter’s reported figure.
CMCSA’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 7.22%.
Let us see how things are shaping up for the upcoming announcement.
Factors to ConsiderComcast is expected to have entered the second quarter of 2026 with operating momentum remaining fragile, reflecting a continuation of pressures signaled following the first quarter print. In Connectivity & Platforms, broadband performance likely stayed under strain as fiber overbuild and fixed wireless competition intensified, and satellite entrants added incremental promotional pressure. Broadband ARPU is expected to have remained under incremental pressure through the second quarter before meaningful relief materializes later in the year, reflecting the absence of a rate increase, continued migration to simplified pricing and the dilutive impact of free wireless line adoption. These dynamics are expected to have kept segment EBITDA growth constrained even as connect volumes and voluntary churn showed tentative stabilization, with elevated marketing spend tied to the go-to-market pivot likely weighing on margins.
Wireless growth likely remained comparatively resilient but is expected to have offered limited near-term financial benefit, as a large share of free line additions had not yet converted to paying relationships. Business Services growth is likely to have moderated modestly amid persistent small business competitive intensity.
Within Content & Experiences, the absence of a comparable sports calendar following the dense first quarter is expected to have weighed on Media segment advertising and distribution growth sequentially. Peacock profitability progress remains uncertain given continued exposure to NBA rights amortization and an intensely competitive streaming landscape. Theme Parks results are expected to have faced continued international headwinds, with softer China-related inbound travel trends pressuring Osaka attendance and a challenging macroeconomic backdrop weighing on Beijing.
What Our Model SaysAccording to the Zacks model, the combination of a positive Earnings ESP and Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. But that is not the case here.
Comcast currently has an Earnings ESP of +2.29% and a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Stocks to ConsiderHere are some stocks worth considering, as our model shows that these have the right combination of elements to beat on earnings this reporting cycle.
Amphenol (APH - Free Report) has an Earnings ESP of +1.12% and a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Amphenol shares have gained 11.9% year to date. Amphenol is scheduled to report its second-quarter 2026 results on July 29.
ASE Technology (ASX - Free Report) has an Earnings ESP of +21.21% and a Zacks Rank #1.
ASE Technology shares have surged 138.6% year to date. ASE Technology is set to report its second-quarter 2026 results on July 30.
Fortive (FTV - Free Report) has an Earnings ESP of +2.82% and a Zacks Rank #2 at present.
Fortive shares have gained 11.9% in the year-to-date period. Fortive is set to report second-quarter 2026 results on July 29.
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Copart, Inc. (“Copart” or the “Company”) (NASDAQ: CPRT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Copart and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On June 29, 2026, Copart announced that Jeff Liaw would step down from his roles as Chief Executive Officer and member of Copart’s board of directors, effective July 31, 2026.
On this news, Copart’s stock price fell $2.45 per share, or 8.02%, to close at $28.10 per share on June 29, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
Jessica Inskip (@jessicainskip) highlights an AI theme for today's Big 3. She turns to Vertiv (VRT) as a company's AI with a strong power backbone, calls Bloom Energy (BE) a “reliable energy aspect” supporting the tech trade, and promise in Alphabet's (GOOGL) new AI chip.
Ally Financial remains a 'hold' as credit risk and aggressive capital management constrain valuation despite stable credit trends and solid loan growth. Q2 EPS missed by a penny, with revenue up 10% and net interest margin rising to 3.63%, but charge-offs and delinquencies indicate stabilization rather than improvement. ALLY benefits from Fed rate cuts due to its fixed-rate loan book and floating deposit base but faces NIM pressure if rate hikes resume.
Key Takeaways GEHC's MIM Anyware enables secure, browser-based access to imaging data without local software installation.The platform supports real-time collaboration across oncology workflows, referrals and treatment planning.GE HealthCare also enhanced MIM Maestro and Contour ProtegeAI 2.0 with dose and AI tools. GE HealthCare Technologies Inc. (GEHC - Free Report) recently announced the launch of MIM Anyware, a web-based remote access platform designed to provide secure, healthcare system-controlled access to imaging data and the company's MIM software portfolio. The platform gives authorized users access to MIM software applications from virtually any location through a web browser without needing local software installation. The platform aims to improve collaboration, streamline imaging workflows and support faster clinical decision-making.
Per management, research has demonstrated that effective collaboration among multidisciplinary teams is essential to deliver coordinated, patient-centered care. MIM Anyware was developed to transform how clinicians interact with medical imaging data in virtual settings. By providing secure browser-based access to imaging data and MIM's advanced analysis tools, the platform is intended to help clinicians to focus more on patient care.
Likely Trend of GEHC Stock Following the NewsFollowing the announcement, GEHC shares dropped 0.4% at yesterday’s close. Year to date, the stock has lost 23.4% compared with the industry’s 21.1% decline. However, the S&P 500 has risen 8.7% in the same timeframe.
GE HealthCare's launch of MIM Anyware is expected to strengthen its position in the cloud medical imaging platform market by expanding secure, browser-based access to imaging data and enabling real-time clinical collaboration across care teams. The platform's support for remote workflows, oncology applications and vendor-neutral interoperability aligns with the growing demand for cloud-enabled imaging solutions. This innovation is likely to increase customer adoption of GE HealthCare's portfolio of MIM software solutions.
GEHC currently has a market capitalization of $28.69 billion.
Image Source: Zacks Investment Research
More on MIM AnywareAs healthcare providers manage large volumes of complex imaging data, traditional remote access solutions often struggle with siloed workstations, IT infrastructure requirements and compatibility with modern imaging environments. MIM Anyware overcomes these challenges by ensuring secure, high-performance remote access for physicians, physicists, dosimetrists and other clinicians to work together within the same MIM session. Teams can collaboratively review image registrations, perform routine clinical processing, deploy workflows and evaluate dose information in real time while improving cross-functional collaboration and workflow efficiency.
The platform is much more valuable in cancer care, where treatment planning requires coordination among multidisciplinary teams. MIM Anyware supports radiation oncology workflows by facilitating consultations, referrals, tumor board discussions, clinician education and collaborative treatment planning.
Alongside MIM Anyware, GEHC continues to improve its MIM software portfolio with solutions such as MIM Maestro and MIM Contour ProtégéAI+ 2.0. MIM Maestro now features a reirradiation and composite dose assessment workflow that allows visualization of prior treatment doses on current anatomy, accounts for radiobiological effects and evaluates multiple treatment strategies using rigid or deformable image registration within a unified workflow.
Meanwhile, MIM Contour ProtégéAI+ 2.0 expands the company's AI-powered auto-contouring capabilities with new Magnetic Resonance Brain models and an enhanced Computed Tomography Male Pelvis model, improving contouring accuracy across key anatomical regions.
Together, the vendor-neutral MIM software portfolio supports clinical applications across radiation oncology, radiology, nuclear medicine, theranostics, interventional radiology and urology.
Industry Prospects Favoring the MarketGoing by the data provided by Research and Markets, the cloud medical imaging platform market was valued at $3.59 billion in 2025 and is projected to grow from $4.2 billion in 2026 to $7.86 billion by 2030, at a CAGR of 16.9% from 2026 to 2030.
Factors like growing implementation of AI-enabled imaging tools, increasing migration toward hybrid cloud deployment models, rising demand for multi-facility image sharing and collaboration, expansion of healthcare digitalization initiatives in emerging economies and increasing focus on workflow automation in radiology departments are boosting the market’s growth.
Other NewsRecently, GEHC announced a new research collaboration with Mayo Clinic to advance personalized cancer treatment through the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) study. The initiative will evaluate whether imaging, blood-based biomarkers and clinical data can help tailor radioligand therapy for patients with advanced prostate cancer, supporting more adaptive treatment decisions and expanding the use of theranostics.
GEHC’s Zacks Rank & Key PicksCurrently, GEHC has a Zacks Rank #4 (Sell).
Some better-ranked stocks from the broader medical space are West Pharmaceutical (WST - Free Report) , Intuitive Surgical (ISRG - Free Report) and Cardinal Health (CAH - Free Report) .
West Pharmaceutical, currently sporting a Zacks Rank #1 (Strong Buy), reported first-quarter 2026 earnings per share (EPS) of $2.13, which beat the Zacks Consensus Estimate by 26.8%. Revenues of $844.9 million surpassed the Zacks Consensus Estimate by 8.5%. You can see the complete list of today’s Zacks #1 Rank stocks here.
West Pharmaceutical has an estimated long-term earnings growth rate of 14.4%. WST’s earnings surpassed estimates in the trailing four quarters, the average surprise being 19.4%.
Intuitive Surgical, currently carrying a Zacks Rank #2 (Buy), reported second-quarter 2026 adjusted EPS of $2.80, which beat the Zacks Consensus Estimate by 12.9%. Revenues of $2.89 billion surpassed the Zacks Consensus Estimate by 3.1%.
Intuitive Surgical has an estimated long-term earnings growth rate of 14.3%. ISRG’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 16.5%.
Cardinal Health, currently carrying a Zacks Rank #2, reported a third-quarter fiscal 2026 adjusted EPS of $3.17, which beat the Zacks Consensus Estimate by 13.2%. Revenues of $60.94 billion missed the Zacks Consensus Estimate by 2.3%.
Cardinal Health has an estimated long-term earnings growth rate of 17%. CAH’s earnings surpassed estimates in the trailing four quarters, the average surprise being 10.3%.
Investors might want to bet on Exelon (EXC - Free Report) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.
The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.
Therefore, the Zacks rating upgrade for Exelon basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
For Exelon, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.
Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for ExelonFor the fiscal year ending December 2026, this energy company is expected to earn $2.86 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for Exelon. Over the past three months, the Zacks Consensus Estimate for the company has increased 0.1%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Exelon to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Key Takeaways Steven Madden raised fiscal 2026 revenue growth guidance to 10-12% and introduced adjusted EPS guidance.SHOO's DTC revenues jumped 83.8%, with 8% growth excluding Kurt Geiger and 17% U.S. comparable sales.Kurt Geiger posted 23% pro forma revenue growth and expanded with new U.S. stores and an India agreement. Steven Madden, Ltd. (SHOO - Free Report) continues to strengthen its growth profile through robust direct-to-consumer (DTC) performance and the continued success of the Kurt Geiger brand. In the first quarter of 2026, the company delivered healthy consumer demand across its portfolio, with strong execution in product innovation and marketing helping offset ongoing softness in its private-label business. Management believes these strengths position the company for improved earnings and sustainable long-term growth.
Steven Madden's DTC business posted another strong quarter. Revenues increased 83.8% year over year to $206 million, primarily reflecting the addition of Kurt Geiger. Excluding the acquisition, DTC revenues still rose 8%, driven by growth across both brick-and-mortar stores and e-commerce. The Steven Madden brand delivered a 17% increase in U.S. comparable sales, supported by exceptional performance in full-price channels. Global DTC comparable sales increased 6%, or by 10% excluding stores in the Middle East. Management also highlighted reduced promotional activity, improving outlet performance and stronger customer engagement as positive trends during the quarter.
The company's product and marketing strategy continued to support DTC momentum. The Steven Madden brand gained traction across casual shoes, dress shoes and boots, benefiting from consumer interest in split toes, mesh, ballet-inspired styles, hidden wedges and Velcro designs. The "Hello Spring" campaign featuring Delilah Belle, combined with a full-funnel marketing approach, boosted customer acquisition and increased online searches for the Steven Madden brand by 27% during the quarter. Management reiterated its expectation for mid- to high-single-digit revenue growth for the Steven Madden brand in fiscal 2026.
Kurt Geiger exceeded expectations during the quarter. The brand generated 23% pro forma revenue growth, driven by continued strength in handbags, footwear and digital channels. Steven Madden secured leases for four new full-price stores and one premium outlet in the United States during 2026 while signing a franchise and distribution agreement with Reliance Brands to launch Kurt Geiger in India beginning in the fourth quarter. Reflecting the brand's strong momentum, management raised its full-year expectation for Kurt Geiger to deliver mid-teens pro forma revenue growth.
Encouraged by strong trends across its key brands, Steven Madden raised its fiscal 2026 revenue growth guidance to 10-12% from the prior 9-11% range and introduced adjusted earnings per share guidance of $2.00-$2.10. Management expects the combination of strong DTC demand, Kurt Geiger's continued expansion and healthy momentum across its branded portfolio to support strong top and bottom-line growth for the remainder of fiscal 2026.
SHOO’s Price Performance, Valuation & EstimatesShares of the company have risen 69.7% over the past year against the industry’s 34% decline.
Image Source: Zacks Investment Research
From a valuation standpoint, Steven Madden is trading at a trailing 12-month price-to-sales ratio of 1.18, down from the industry average of 1.33.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Steven Madden’s 2026 earnings implies year-over-year growth of 22.9%, whereas the same for 2027 indicates an uptick of 33.8%. Estimates for 2026 and 2027 have been revised upward by 3 cents and 16 cents, respectively, over the past 60 days.
Image Source: Zacks Investment Research
SHOO’s Zacks Rank & Other Key PicksSteven Madden currently sports a Zacks Rank #1 (Strong Buy).
Genesco Inc. (GCO - Free Report) is a Nashville-based specialty retailer and branded company. It sells footwear and accessories through retail stores. The company flaunts a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Genesco’s current fiscal-year earnings indicates growth of 55.2% from the year-ago actuals. GCO delivered a trailing four-quarter average earnings surprise of 3.8%.
Designer Brands Inc. (DBI - Free Report) designs, produces and retails footwear and accessories. It offers shoes, boots, sandals, sneakers, socks, handbags and accessories. It currently carries a Zacks Rank #1.
The Zacks Consensus Estimate for Designer Brands’ current fiscal-year earnings and sales suggests growth of 137.5% and 0.5%, respectively, from the year-ago actuals. DBI delivered a trailing four-quarter average earnings surprise of 112.8%.
Tapestry, Inc. (TPR - Free Report) is the designer and marketer of fine accessories and gifts for women and men in the United States and internationally. The company also holds a Zacks Rank #2 at present.
The Zacks Consensus Estimate for Tapestry’s current fiscal-year earnings and sales indicates growth of 36.5% and 13.9%, respectively, from the year-ago actuals. TPR delivered a trailing four-quarter average earnings surprise of 15.6%.
Key Takeaways Teledyne Technologies is expected to benefit from strength in defense electronics and acquisitions.TDY's Digital Imaging unit likely gained from demand for infrared imaging and unmanned systems.Teledyne Technologies is expected to report 11.2% EPS growth and 3.7% higher quarterly revenues. Teledyne Technologies, Inc. (TDY - Free Report) is scheduled to release second-quarter 2026 results on July 22, before market open. The company delivered an earnings surprise of 5.84% in the last reported quarter.
Let’s discuss the factors that are likely to be reflected in the upcoming quarterly results.
Key Factors Likely to Influence TDY’s Q2 ResultsDuring the second quarter of 2026, Teledyne Technologies' Aerospace & Defense Electronics unit is expected to have benefited from solid organic sales of defense electronics products, along with revenue contributions from recent acquisitions, supporting its top-line performance.
The Instrumentation segment is likely to have generated higher revenues, driven by increased sales of marine instruments and underwater autonomous vehicles.
Increased sales of infrared imaging subsystems, coupled with robust demand for unmanned air systems and unmanned maritime surface vehicles, are likely to have supported the top-line growth of the Digital Imaging segment.
TDY’s Q2 ExpectationsThe Zacks Consensus Estimate for earnings is pegged at $5.78 per share, indicating a year-over-year increase of 11.2%.
The consensus estimate for revenues is pinned at $1.57 billion, calling for a year-over-year improvement of 3.7%.
What the Zacks Model Unveils for TDYOur proven model predicts an earnings beat for Teledyne Technologies this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is the case here, as you will see below.
Other Stocks to ConsiderInvestors may consider the following players from the same industry as these also have the right combination of elements to post an earnings beat this reporting cycle.
Woodward, Inc. (WWD - Free Report) is expected to report its fiscal third-quarter 2026 earnings on July 29, after market close. It has an Earnings ESP of +5.10% and a Zacks Rank of 2 at present.
The Zacks Consensus Estimate for WWD’s earnings is pegged at $2.39 per share, indicating year-over-year growth of 35.8%. The consensus estimate for its sales stands at $1.11 billion, calling for a year-over-year increase of 21.7%.
Curtiss-Wright Corporation (CW - Free Report) is set to report second-quarter 2026 earnings on Aug. 5, after market close. It has an Earnings ESP of +0.36% and a Zacks Rank of 2 at present.
The Zacks Consensus Estimate for CW’s earnings is pegged at $3.62 per share, indicating a year-over-year rise of 12.1%. The consensus estimate for its sales stands at $930.9 million, implying a year-over-year increase of 6.2%.
ATI Inc. (ATI - Free Report) is expected to report its second-quarter 2026 earnings on Aug. 6, before market open. It has an Earnings ESP of +3.10% and a Zacks Rank of 2 at present.
The Zacks Consensus Estimate for ATI’s earnings is pegged at $1.02 per share, suggesting year-over-year growth of 37.8%. The consensus estimate for its sales stands at $1.22 billion, calling for a year-over-year jump of 7.3%.
Tenable's rally has rewarded stronger fundamentals, but a near-peer sales multiple, limited price-target upside and execution risks argue for patience.
Key Takeaways Tenable is using Hexa AI to automate risk triage and remediation across exposure management workflows. TENB is expanding Tenable One with cloud, identity, OT security and 300 pre-built integrations.TENB partners with OpenAI and Anthropic while proving AI advantages can drive sustained growth. Tenable Holdings (TENB - Free Report) sits near the center of a cybersecurity shift shaped by artificial intelligence. As AI accelerates vulnerability discovery and shortens the time between exposure and exploit, enterprises need faster ways to identify, prioritize and remediate risk.
That backdrop supports demand for unified exposure management. TENB’s challenge is turning that trend into durable product differentiation, sustained execution and better stock performance.
Tenable Benefits From a Faster Threat CycleAI is changing the pace of cyber defense. Frontier models are making vulnerability discovery faster, increasing pressure on security teams that already manage sprawling IT, cloud, identity and operational technology environments.
That urgency supports platforms that unify visibility, context and action. Narrow point products may still solve specific problems, but exposure management becomes more valuable when buyers need to understand which risks matter most and how quickly they can be fixed.
The competitive field is broad. Qualys (QLYS - Free Report) and Rapid7 (RPD - Free Report) remain relevant vulnerability management peers, while CrowdStrike, Palo Alto Networks (PANW - Free Report) and Wiz compete from adjacent areas such as endpoint and cloud security. That peer set underscores why TENB must keep expanding beyond traditional vulnerability scanning.
TENB Uses Hexa AI to Deepen Platform ValueTenable’s AI strategy centers on automation. Hexa AI is positioned as an agentic orchestration engine designed to automate triage and remediation workflows, helping turn exposure intelligence into action at machine speed.
That matters because buyers are not just looking for more alerts. They need systems that can prioritize risks and accelerate response. Hexa AI’s tiered packaging is also expected to support higher average selling prices over time.
Flex pricing adds another adoption lever. By simplifying per-asset procurement, Flex pricing may reduce friction as customers expand their exposure management footprint.
Qualys and Rapid7 are natural comparison points because security buyers often evaluate vulnerability management platforms against each other. TENB’s task is to show that Hexa AI and Tenable One create a broader operating model rather than simply adding another AI feature.
Tenable Pushes Into Cloud, Identity and OTPlatform convergence is central to the TENB story. Tenable One combines vulnerability management with cloud security, identity exposure, operational technology security, web app scanning and attack surface management.
That breadth gives TENB a wider role across modern attack surfaces. The company has also added native operational technology discovery capabilities, extending visibility into cyber-physical systems without additional hardware.
Recent milestones strengthen that platform narrative. Tenable’s cloud security platform achieved FedRAMP High and Impact Level 5 authorization, improving its ability to support U.S. federal agencies. The company also announced AI-powered cloud detection and response capabilities and more than 300 pre-built integrations through the Tenable One Open Connector.
CrowdStrike, Palo Alto Networks and Wiz highlight the pressure from larger and cloud-focused security platforms. Their presence makes TENB’s push into cloud, identity and operational technology more necessary as customers consolidate security spending.
TENB Must Keep Its AI Edge From NarrowingThe same AI trend expanding demand also raises competitive risk. If AI lowers the cost and complexity of building vulnerability discovery and prioritization tools, adjacent vendors could move deeper into exposure management.
That risk is not abstract. Qualys, Rapid7, CrowdStrike, Palo Alto Networks and Wiz are all capable of narrowing TENB's AI edge if they close the gap on automation and prioritization.
Partnerships with OpenAI and Anthropic help TENB stay close to frontier model development. Tenable has participated in OpenAI’s Trusted Access for Cyber program and has worked with Anthropic to integrate Claude-powered workflows into Hexa AI.
Those relationships are useful, but they are not enough on their own. Because they are non-exclusive, TENB still has to convert early access into durable product advantages that are hard for peers to replicate.
Tenable’s Ratings Reflect Trend Strength, Stock RiskThe bottom line is that TENB is tied to a powerful cybersecurity trend, but the stock still carries execution risk. AI-driven vulnerability discovery may continue to lift demand for exposure management, yet TENB must prove that platform breadth, automation and partner access can translate into sustained growth.
The Zacks Consensus Estimate for TENB’s 2026 earnings is pegged at $1.95 per share, unchanged over the past 30 days and indicating 22.64% year-over-year growth.
TENB currently carries a Zacks Rank #4 (Sell). That rank points to a weak short-term earnings estimate revision setup, even though the company has favorable Style Scores.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The stock has a Growth Score of A, Momentum Score of A and VGM Score of A. These scores suggest favorable growth and momentum characteristics, but Style Scores are best used with the Zacks Rank. For now, the trend is promising, while the stock still needs clearer proof of sustained execution and improved estimate momentum.
Key Takeaways Tenable is expanding from vulnerability scanning into an AI-enabled exposure management platform.TENB said Tenable One made up 41% of Q1 2026 new business, up 800 basis points year over year.Tenable added AI, cloud and identity capabilities through acquisitions, partnerships and Flex pricing. Tenable Holdings (TENB - Free Report) is no longer defined only by vulnerability scanning. The company is positioning itself as an exposure management platform that helps customers see, prioritize and reduce cyber risk across a widening attack surface.
That shift is central to the TENB stock story. Tenable One, Hexa AI, cloud security, identity exposure, operational technology security and AI asset visibility now shape the platform thesis.
Tenable Expands Beyond Legacy ScanningTenable’s business centers on exposure management across information technology, cloud, operational technology, web applications, identity systems and emerging AI assets. The goal is to give customers a unified view of where risk exists, what matters most and which issues need remediation.
Tenable One is the company’s flagship AI-enabled exposure management platform. It integrates vulnerability management, cloud security, identity exposure, operational technology security, web application scanning and attack surface management. Legacy products such as Nessus remain available as stand-alone offerings, keeping the company connected to its vulnerability management roots.
Acquisitions have widened the platform. Tenable acquired Vulcan Cyber in 2025 to add cyber risk management capabilities and Apex Security to expand AI attack surface security. Those deals support the broader move from scanning toward risk prioritization and action.
Qualys (QLYS - Free Report) and Rapid7 (RPD - Free Report) remain relevant comparisons because both operate in vulnerability management and related security markets. Their presence keeps pressure on Tenable to prove that broader exposure management can deliver more value than point tools. Where Qualys and Rapid7 have built primarily around vulnerability management, Tenable has pushed earlier into adjacent categories such as cloud security, identity exposure and OT, positioning Tenable One as a broader consolidation point for security budgets. Palo Alto Networks (PANW - Free Report) , by comparison, has scaled its platform out of network security, firewalls and cloud, giving it a different but overlapping path into exposure-adjacent workflows.
TENB Gains Traction With Tenable OneTenable One accounted for 46% of new business in fiscal 2025. In the first quarter of 2026, the platform represented 41% of new business, up 800 basis points year over year.
That momentum included 406 new enterprise platform customers and 43 net new six-figure customers in the quarter, alongside a net dollar expansion rate of 105%. Management also cited strong new logo activity, including a seven-figure Tenable One transaction with a major financial institution in the Middle East where Tenable displaced an incumbent vulnerability management vendor.
The driver is clear. Customers are dealing with more assets, more vulnerabilities, more identities and more cloud complexity. Tenable's pitch is that unified visibility, contextual prioritization and remediation workflows can reduce noise and focus security teams on the most important exposures.
Palo Alto Networks is another relevant name because large cybersecurity platforms are expanding across cloud and broader security operations. That makes Tenable's differentiation in exposure management important as platform competition intensifies. That new business mix also points to a broader shift in spend toward consolidated platforms, away from the narrower vulnerability management offerings that still anchor Qualys and Rapid7's core business.
Tenable Ties AI to Faster Customer AdoptionAI is not just a marketing layer in Tenable's story. Management has pointed to the rapid advancement of frontier AI models, including Anthropic's Mythos, as evidence that vulnerability discovery is accelerating at a scale and speed not seen before. That dynamic, in management's view, raises the urgency for customers to prioritize and remediate exposures faster.
Hexa AI is Tenable’s agentic orchestration engine for the Tenable One platform. It is designed to automate triage and remediation workflows, turning exposure intelligence into coordinated action across security tools, teams and systems. Palo Alto Networks has taken a similar path, layering AI copilots and automation across its own platform, keeping the competitive bar high for autonomous remediation.
Tenable also introduced Flex pricing in the first quarter of 2026. The model keeps pricing per asset but applies consistent pricing across asset types, which management said can reduce procurement friction as customers expand across the attack surface.
Partnerships with OpenAI and Anthropic add another layer to the strategy. Tenable has integrated Claude-powered workflows into Hexa AI and joined OpenAI's Trusted Access for Cyber and Daybreak Cyber Partner programs, bringing frontier model capabilities directly into the platform. TENB has also expanded AI governance through the Tenable One Open Connector network, the Claude Compliance API and FedRAMP High authorization for its cloud platform.
Tenable Still Faces Real Execution RisksThe bull case still has constraints. Tenable generated 94% of its 2025 revenues through channel partners, and one distributor accounted for 32% of revenues and 28% of accounts receivable.
That concentration creates dependence on third-party relationships for sales reach, collections and customer visibility. A change in distributor terms, strategy or financial position could create disruption that is not fully under Tenable’s direct control.
Integration risk also matters. Vulcan Cyber and Apex Security add capabilities, but acquisitions require technology, product and sales integration. Slower integration could distract management or delay the expected benefits of the broader platform.
International exposure adds another risk. In 2025, 39% of revenues came outside the Americas, with 27% from Europe, the Middle East and Africa and 12% from Asia Pacific. Currency movement can affect reported growth even when underlying demand remains intact.
AI could also cut both ways. The same advances that increase demand for exposure management may help competitors build overlapping discovery, prioritisation and remediation features over time.
Tenable’s Scores Show a Mixed but Active SetupTenable’s platform narrative is compelling, but the stock setup is not cleanly bullish in the near term. The company is building around Tenable One, Hexa AI and AI-driven exposure management at a time when customers are reassessing how quickly they can identify and fix cyber risk.
TENB currently carries a Zacks Rank #4 (Sell). That points to weaker short-term earnings estimate revision momentum, which investors should weigh carefully before treating the stock’s business narrative as a direct buy signal. The Zacks Consensus Estimate for TENB's 2026 EPS is pegged at $1.95, unchanged over the past 30 days and indicating 22.64% year-over-year growth, which shows why the earnings picture still lags the stock's broader momentum story.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Tenable Holdings, Inc. Price and Consensus
Tenable Holdings, Inc. price-consensus-chart | Tenable Holdings, Inc. Quote
The Style Scores are stronger. TENB has a VGM Score of A, Growth Score of A and Momentum Score of A, while its Value Score is D. Style Scores are designed to complement the Zacks Rank, with A and B grades generally more favorable than weaker grades.
The combination leaves TENB in a mixed but active position. The growth and momentum profile supports interest in the platform story, but the Zacks Rank #4 signals caution around near-term earnings revision trends.
Key Takeaways Huntington's Q2 earnings are estimated to be 39 cents per share, suggesting a rise of 2.6% year over year.Revenues are projected to be $2.8 billion, reflecting 41.7% growth from the prior-year quarter.Higher NII and fee income are likely to support results, while elevated expenses remain a headwind. Huntington Bancshares Incorporated (HBAN - Free Report) is slated to report second-quarter 2026 results on July 23, before the opening bell. The company’s quarterly revenues and earnings are expected to have increased year over year.
In the last reported quarter, the bank’s results reflected improvements in net interest income (NII) and non-interest income. Higher loan and deposit balances also acted as tailwinds. However, an increase in non-interest expenses and higher provisions offset these positives.
HBAN has a decent earnings surprise history. Its earnings surpassed the Zacks Consensus Estimate in two of the trailing four quarters, matched once and missed once, with an average earnings surprise of 0.73%.
Now, let us discuss the factors that are likely to have influenced Huntington’s second-quarter performance.
Key Factors & Estimates for HBAN’s Q2 PerformanceLoans & NII: In the second quarter of 2026, the Federal Reserve left interest rates unchanged at 3.50-3.75%, noting that economic activity continued to expand at a solid pace despite elevated uncertainty, while inflation remained above its 2% target. Against this backdrop, HBAN's NII is expected to have improved in the to-be-reported quarter.
The Zacks Consensus Estimate for NII is pegged at $2.1 billion, suggesting a 10.7% increase from the year-ago quarter's reported level.
Per the Fed’s latest data, demand for commercial and industrial and consumer loans remained decent in the second quarter of 2026, while real estate loan demand was relatively modest. Hence, a stable interest rate environment and healthy loan demand are expected to have supported Huntington's growth in average interest-earning assets in the to-be-reported quarter.
The Zacks Consensus Estimate for average total earning assets is pegged at $262.1 billion, indicating a 37.1% increase from the prior-year quarter's reported level.
Non-Interest Income: Mortgage activity remained challenging in the second quarter of 2026, with mortgage rates hovering around the mid-6.5% range and affordability remaining strained. While purchase activity continued to face pressure from inventory constraints, refinancing activity improved modestly. As such, HBAN's mortgage banking income is likely to have improved in the to-be-reported quarter.
The Zacks Consensus Estimate for mortgage banking income is pegged at $42.1 million, suggesting a 50.2% increase from the prior-year quarter's reported figure.
Global mergers and acquisitions (M&As) activity moderated in the second quarter of 2026 after a strong start to the year, as ongoing geopolitical uncertainty, elevated inflation, a persistent backlog of private equity exits and higher interest rates weighed on deal-making. While deal values declined as only a few large transactions dominated the market, M&A volumes improved year over year.
Despite the challenging backdrop, higher M&A deal volumes are expected to have driven strong growth in HBAN's capital markets and advisory fees in the to-be-reported quarter.
The Zacks Consensus Estimate for capital markets and advisory fees is pegged at $137.5 million, indicating a 63.6% rise on a year-over-year basis.
The Zacks Consensus Estimate for wealth and asset management revenues is pegged at $127 million, suggesting a 5.8% rally from the year-ago reported figure.
The consensus estimate for customer deposit and loan fees for the second quarter is pegged at $118 million, indicating 24.2% year-over-year growth.
The consensus estimate for total non-interest income is pegged at $727.8 million, indicating a 54.5% increase from the year-ago reported figure.
Expenses: Huntington's higher personnel costs, along with increased outside data processing, technology, marketing and other service-related expenses, are anticipated to have raised its costs in the second quarter of 2026. Further, the bank's ongoing investments to expand its commercial banking capabilities in high-growth markets and complete systems conversion work are likely to have kept expenses elevated.
While efficiency initiatives are expected to have provided some offset, long-term investments in growth initiatives and acquisition-related expenses associated with the Cadence transaction are likely to have kept the company's expense base higher.
Asset Quality: The operating environment remained challenging in the second quarter of 2026, weighed down by persistent geopolitical uncertainty and elevated inflation. Additionally, the Fed's June policy statement indicated the possibility of a rate hike, which could pressure borrowers' repayment capacity.
Against this backdrop, HBAN is expected to have maintained a cautious approach and built higher provisions for potential credit losses in the to-be-reported quarter.
What Does Our Model Unveil for HBAN?Our proven model does not predict an earnings beat for Huntington this time. The combination of a positive Earnings ESP and Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That is not the case here, as you can see below.
You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Earnings ESP: Huntington Bancshares has an Earnings ESP of 0.00%.
Zacks Rank: HBAN currently carries a Zacks Rank of 3.
The Zacks Consensus Estimate for Huntington Bancshares’ second-quarter earnings of 39 cents per share has been unchanged over the past seven days. The figure suggests a 2.6% rise from the year-ago reported number.
The consensus estimate for revenues is pegged at $2.8 billion, indicating a year-over-year increase of 41.7%.
Stocks to ConsiderHere are a couple of other bank stocks that you may want to consider, as our model shows that these also have the right combination of elements to post an earnings beat this time around.
The Earnings ESP for First Hawaiian (FHB - Free Report) is +0.84%, and it carries a Zacks Rank #1 at present. The company is slated to report second-quarter 2026 results on July 24. You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past seven days, the Zacks Consensus Estimate for FHB’s quarterly earnings has been revised upward to 60 cents per share.
Prosperity Bancshares (PB - Free Report) is scheduled to report second-quarter 2026 results on July 29, 2026. The company has an Earnings ESP of +1.76% and a Zacks Rank #3 at present.
Quarterly earnings estimates for PB have been unchanged at $1.54 per share over the past week.
The top-rated strong-buy stocks on Marketbeat’s radarWintrust Financial NASDAQ: WTFC reported what management described as a “very strong, straightforward quarter,” with record net income, broad-based loan growth, strong deposit inflows and stable credit quality in the second quarter of 2026.
President and CEO Tim Crane said the quarter marked Wintrust’s sixth consecutive record quarter of net income. The company reported second-quarter net income of $233.7 million, up from just over $227 million in the first quarter. Year-to-date net income was $461 million, up 20% from the same period last year.
Get Wintrust Financial alerts:
Crane said the results reflected Wintrust’s focus on three strategic priorities: delivering a differentiated customer experience, generating disciplined growth and investing for the future. He said the company’s growth during the quarter was entirely organic, adding that Wintrust continued to gain market share “one client, one relationship at a time.”
Deposits and Loans Grow Sharply Vice Chairman and Chief Operating Officer Dave Dykstra said deposits increased by approximately $2.2 billion during the quarter, representing a 15% annualized increase from the prior quarter. That growth funded loan growth of approximately $1.6 billion, or 12% annualized.
Dykstra said interest-bearing deposit costs were flat from the prior quarter at 2.74%, despite the significant increase in deposits. Loan yields declined seven basis points to 6.07%, primarily due to repricing in the commercial insurance premium finance portfolio and modest spread compression from competitive market pressures.
Crane said deposit growth was helped by municipal seasonality, commercial growth and retail growth. He said Wintrust expects strong deposit growth in the second half of the year, though not at the same level as the second quarter. He also said pricing in the market remains “relatively rational.”
Vice Chairman and Chief Lending Officer Richard Murphy said loan growth was broad-based, with every lending segment posting positive growth. The first insurance funding portfolio grew $722 million, while commercial loans increased $518 million, supported by production in asset-based lending and leasing. Commercial real estate loans rose $108 million, and the Wintrust Life Finance portfolio grew by $116 million.
Net Interest Margin Remains Stable Net interest income improved by $18.3 million from the first quarter, Dykstra said, helped by a $2.1 billion increase in average earning assets. That benefit was partially offset by a four-basis-point decline in net interest margin.
The net interest margin was 3.52% in the second quarter. Dykstra said the margin has ranged from 3.50% to 3.59% over the past 10 quarters, demonstrating stability. Management continues to expect the margin to remain within a few basis points of 3.50%.
Dykstra said competitive pressure was not dramatic but was visible in some commercial, commercial real estate and premium finance transactions. He said Wintrust is declining deals where pricing does not meet its standards, particularly larger premium finance loans priced “awfully thin.”
Crane said the company expects solid net interest income growth and good operating leverage regardless of the precise margin level.
Expenses Rise, but Management Points to Operating Leverage Non-interest income totaled $141.3 million in the second quarter, up from $134.1 million in the first quarter. Dykstra said the increase was primarily driven by a $4 million improvement in mortgage banking revenue, about $2 million in higher bank-owned life insurance income and approximately $1.8 million more in securities gains.
However, Dykstra cautioned that those items can be volatile and may not recur at the same level in the third quarter. He said the company currently expects mortgage revenue to fall back into the low $20 million range as homebuying seasonality subsides.
Non-interest expense rose to $397.5 million from $382.6 million in the prior quarter. Dykstra attributed the increase to several factors, including the full-quarter effect of annual merit increases, higher mortgage-related commissions, higher deferred compensation expense related to BOLI and a seasonal increase in advertising and marketing tied to sports sponsorships and summer community events.
Those increases were partially offset by a $5.2 million reversal of accrued FDIC assessment expense related to a final true-up of the special assessment imposed after two bank failures in 2023. Dykstra said Wintrust remains on track for mid-single-digit expense growth in 2026 compared with 2025.
Credit Quality Remains Stable Murphy said Wintrust continued to see strong credit performance across its portfolio. Non-performing loans decreased to $179.3 million, or 0.32% of loans, from $182.7 million, or 0.34%, in the prior quarter. Charge-offs declined to 10 basis points from 14 basis points.
Murphy said the figures reflect a stable credit environment and Wintrust’s focus on identifying problem credits early and charging them down where appropriate.
The company continues to closely monitor its commercial real estate exposure, which represents roughly one-quarter of the total loan portfolio. Murphy said CRE non-performing loans remained unchanged from the first quarter at 0.12%, while CRE charge-offs remained at historically low levels.
Wintrust’s CRE office exposure stood at $1.6 billion, or 11.3% of the total CRE portfolio and 2.9% of total loans. Murphy said the company performs quarterly deep-dive reviews of the office portfolio and that the most recent analysis showed results consistent with prior quarters.
Branch Expansion and Wealth Management Investment Crane said Wintrust plans to open several branches during the remainder of the year. New locations in Chicago’s Lakeview neighborhood and in Montgomery and Elk Grove Village, Illinois, are expected to open in the coming weeks, with additional locations later in the quarter, including three in Northwest Indiana.
Crane also highlighted Wintrust’s July 6 announcement that it intends to purchase Northern Trust’s guardianship services business. He described the transaction as a “good bolt-on acquisition” for Wintrust’s wealth management business and said it is expected to close later this year.
Management said Wintrust is also continuing to invest in digital banking, with new consumer and business features expected in the third quarter. Crane said those investments are intended to support the company’s customer experience and long-term growth.
Looking ahead, Crane said Wintrust’s targets remain unchanged: mid- to high-single-digit loan growth, deposit growth sufficient to largely fund loan growth, well-managed expenses, stable credit performance and rising CET1 and other capital ratios in coming quarters.
About Wintrust Financial (NASDAQ:WTFC)Wintrust Financial Corporation is a Chicago‐area bank holding company headquartered in Rosemont, Illinois. Through its primary subsidiary, Wintrust Bank, the company operates a network of community banks serving metropolitan Chicago and select markets in southeastern Wisconsin. These locally branded banks provide personalized commercial and consumer banking solutions tailored to small and mid‐size businesses, professionals, and individual clients.
The firm's core offerings include deposit products, commercial and residential lending, treasury management, and mortgage banking services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Wintrust Financial Right Now?Before you consider Wintrust Financial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Wintrust Financial wasn't on the list.
While Wintrust Financial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at Humana (HUM - Free Report) , which currently has a Momentum Style Score of A. We also discuss some of the main drivers of the Momentum Style Score, like price change and earnings estimate revisions.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Humana currently has a Zacks Rank of #1 (Strong Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market? In order to see if HUM is a promising momentum pick, let's examine some Momentum Style elements to see if this health insurer holds up.
Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It's also helpful to compare a security to its industry; this can show investors the best companies in a particular area.
For HUM, shares are up 1.98% over the past week while the Zacks Medical - HMOs industry is down 1.35% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 10.39% compares favorably with the industry's 0.66% performance as well.
Considering longer term price metrics, like performance over the last three months or year, can be advantageous as well. Shares of Humana have increased 78.07% over the past quarter, and have gained 78.22% in the last year. In comparison, the S&P 500 has only moved 4.95% and 19.48%, respectively.
Investors should also take note of HUM's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. Right now HUM is averaging 1,370,639 shares for the last 20 days..
Earnings OutlookThe Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with HUM.
Over the past two months, 2 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost HUM's consensus estimate, increasing from $9.02 to $9.25 in the past 60 days. Looking at the next fiscal year, 2 estimates have moved upwards while there have been no downward revisions in the same time period.
Bottom LineTaking into account all of these elements, it should come as no surprise that HUM is a #1 (Strong Buy) stock with a Momentum Score of A. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Humana on your short list.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Labcorp Holdings (LH - Free Report) , which belongs to the Zacks Medical Services industry, could be a great candidate to consider.
This medical laboratory operator has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 3.47%.
For the most recent quarter, Labcorp was expected to post earnings of $4.09 per share, but it reported $4.25 per share instead, representing a surprise of 3.91%. For the previous quarter, the consensus estimate was $3.95 per share, while it actually produced $4.07 per share, a surprise of 3.04%.
Price and EPS Surprise
Thanks in part to this history, there has been a favorable change in earnings estimates for Labcorp lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Labcorp has an Earnings ESP of +0.71% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #2 (Buy), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on July 30, 2026.
Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.
Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Retirees are hunting for durable monthly and quarterly checks that keep landing regardless of who wins the news cycle. Five names anchor that shortlist right now, and the group averages a payout that trounces the S&P 500’s sub-2% yield: Ares Capital pays a 10.3% dividend yield and AGNC Investment pays 12.7%, both well above what Treasuries or index funds are offering in mid-2026. Here is how the five stack up on safety, coverage, and staying power.
Altria Group Altria (NYSE:MO | MO Price Prediction) is the classic boomer income name, and it still earns the label. The tobacco giant currently yields 5.96% on a quarterly dividend that was raised from $1.02 to $1.06 per share effective with the March 2026 payment, an annualized run rate of $4.24.
Dividend safety is the whole story here. Trailing EPS of $4.96 comfortably covers the $4.24 payout, and management’s FY26 adjusted EPS guidance of $5.56 to $5.72 pushes coverage further into the safe zone. Altria paid $7.0 billion in dividends for full-year 2025 while still returning capital via buybacks. The dividend track record is one of the longest in the market, with regular annual increases visible in the data every year going back more than two decades.
The bull case for income investors: a low-beta (0.494), cash-gushing operator trading at a forward P/E of 13 with a nearly 6% yield and a raise almost every year. Shares are up 32.54% over the past year, so this is not a beaten-down setup anymore.
Risk: cigarette volumes remain in secular decline, and Marlboro retail share slipped 1.4 points to 39.7%. If smokeable volumes decelerate faster than pricing can offset, the dividend growth rate compresses.
Verizon Communications Verizon (NYSE:VZ) is the ultra-high-yield telecom that retirees actually own. The stock yields 6.46%, and the board pushed the quarterly payout from $0.69 to $0.7075 per share earlier this year, an annualized rate of $2.83.
Coverage looks solid on a cash basis. Verizon guided FY26 free cash flow to at least $21.5 billion against a dividend obligation that runs a fraction of that. Adjusted EPS guidance of $4.95 to $4.99 against a $2.83 annualized payout implies a payout ratio well under 60%. The dividend growth record here spans 25+ years of uninterrupted quarterly payments with steady annual bumps.
The bull case is boring in the best way: first positive Q1 postpaid phone net adds since 2013, fiber connections jumping 41.9% year over year to about 10.8 million post-Frontier close, and a beta of just 0.238. This is a portfolio stabilizer that pays you to hold it.
Risk: total debt jumped to $172.5 billion after the Frontier close, with net unsecured leverage at 2.6x. If deleveraging stalls, dividend growth stays capped in the low single digits.
Enterprise Products Partners Enterprise Products Partners (NYSE:EPD) is the midstream MLP that income investors treat like a bond substitute. The distribution yield sits at 5.84%, with the latest quarterly payout raised to $0.56 from $0.55 and an annualized forward distribution of $2.24.
Safety is best-in-class for the group. Enterprise generated Q1 2026 distributable cash flow of $2.7 billion and retained $1.5 billion of DCF after distributions, a coverage ratio most retirees only dream about. The distribution has now grown for 27 consecutive years, which is why it gets called a shadow Dividend King. Debt of $34.2 billion is manageable against EBITDA of $9.79 billion, and the model is fee-based, not commodity-price driven.
The bull case: record volumes across the system (NGL fractionation +16%, pipeline +7%, marine +15%), $5.3 billion of growth projects under construction, and a distribution that has literally never gone backward in nearly three decades. The stock is up 28.8% over the past year and 127.84% over five years.
_________________________________
What's Your Number...?Here's a question most people 5y from retirement can't answer: at your current savings rate, how much do you need, and how long will it actually last? A good advisor can put a date on that in a single meeting. SmartAsset's free quiz matches you with up to three fiduciary advisors serving your area, so you can get YOUR retirement number now (sponsor)
__________________________________________
Risk: MLPs issue K-1 tax forms, which complicates filings and generally makes them a poor fit inside IRAs due to UBTI concerns.
Ares Capital Ares Capital (NASDAQ:ARCC) is the largest publicly traded business development company, and it earns the ultra-high-yield tag. The stock pays $1.92 annually for a 10.3% yield, with $0.48 per quarter maintained consistently since Q1 2023.
Coverage runs through net investment income, and it holds up. Q1 2026 net investment income was $0.55 per share against the $0.48 dividend, giving roughly 15% of cushion. The portfolio is $29.5 billion across 603 companies, weighted heavily to first-lien senior secured loans at 73% of new commitments, and non-accruals sit at a manageable 2.1%. Leverage at 1.12x leaves headroom versus the regulatory cap.
The bull case for income buyers: a double-digit yield, a P/E of 11, a price-to-book of 0.952 (essentially at NAV), and a dividend that has been stable or rising through the last three years. Analyst consensus skews positive with 4 Strong Buys and 7 Buys against 3 Holds and zero Sells.
Risk: BDCs live and die by the credit cycle. Non-accruals ticked up from 1.8% and $412 million in net unrealized losses dragged GAAP EPS to $0.13 in Q1. If spreads widen further, NAV takes another leg down.
AGNC Investment AGNC Investment (NASDAQ:AGNC) is the monthly-payer wildcard that retirees either love or avoid entirely. The mortgage REIT pays $0.12 per share monthly, or $1.44 annualized for a 12.7% yield.
Safety is the key question. The monthly $0.12 rate has been held steady for 6+ consecutive years, and Q1 2026 net spread and dollar roll income rose to $0.42 per share from $0.35, comfortably covering the quarterly equivalent of the payout. However, tangible net book value per share fell 5.6% to $8.38 in the quarter, and the company posted a GAAP net loss of $0.17 per share. The dividend was cut from $0.16 to $0.12 back in 2020, so this is not a Dividend Aristocrat story.
The bull case: monthly income, an Agency MBS portfolio of $94.7 billion that carries government backing on the underlying credit risk, and a FY25 economic return on tangible common equity of 22.7%. Shares are up 41.51% over the past year on total return.
Risk: book value volatility is real. AGNC runs 7.4x leverage, so a bad quarter for MBS spreads can erase months of dividend income on the mark-to-market.
The Bottom Line Enterprise Products Partners and Altria are the ballast of this group, offering the strongest coverage and longest raise streaks. Verizon adds low-beta telecom cash flow with a 6%-plus yield that just got another bump. Ares Capital and AGNC layer on the double-digit yields boomers want, with the caveat that BDC credit and mortgage REIT book value swings mean position-sizing matters. Blended together, these five build the kind of income ladder retirees are buying in size and holding indefinitely.
If You’ve Been Thinking About Retirement, Pay Attention (sponsor) Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how:
Answer a Few Simple Questions.
Get Matched with Vetted Advisors
Choose Your Fit
Why wait? Start building the retirement you’ve always dreamed of. Get started today! (sponsor)
New York, New York--(Newsfile Corp. - July 21, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against AeroVironment, Inc. (NASDAQ: AVAV) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AeroVironment securities between June 25, 2025 and March 10, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/AVAV.
AeroVironment Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that:
AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; accordingly, Defendants overstated AeroVironment's business and financial prospects; and as a result, Defendants' public statements were materially false and misleading at all relevant times.What's Next for AeroVironment Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/AVAV, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in AeroVironment you have until July 27, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to AeroVironment Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for AeroVironment Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising.
Prior results do not guarantee similar outcomes.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299091
Source: Bronstein, Gewirtz & Grossman, LLC
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
